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ABSTRACT OF THE DISSERTATION

Impact of a Medically Supervised Weight Management Program on Obese and Morbidly
Obese Persons
by
Gemechu Abraham Kurfessa, DrPH, MPA, RCP
Doctor of Public Health in Preventive Care
Loma Linda University, Loma Linda, California, 2011
Susanne Montgomery, PhD, MPH, Co-Chair
Serena Tonstad, MD, PhD, Co-Chair

Background: Overweight and obesity represent a major public health problem.
While some studies indicate that a clinic-based, healthy-lifestyle program can result in
significant weight loss, a systemic review of major commercial weight loss programs
concluded that the evidence to support the use of such programs is minimal. While few
argue for the need for weight loss in obese individuals it is important to identify factors
associated with successful weight loss. These factors could include financial incentives,
frequency of intervention sessions, use of adjunctive weight loss medications and
supplemental diet products, and availability of group vs. individual therapy sessions. In
addition, pretreatment levels of perceived and actual engagement in healthy lifestyle
behaviors (self-monitoring, exercise and diet) and psychosocial factors could potentially
influence weight loss success.
Purpose: The purpose of this study was to: (a) investigate whether an intensive
weight management program that included funding for program expenses and use of a
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patient contract was associated with clinically significant weight loss in obese and
morbidly obese patients and, (b) identify environmental or psychological factors
associated with successful weight loss.
Methods: We compared the amount of weight loss among patients who contracted
to participate in a 26-week intervention including funding to offset program expenses and
a signed participation contract (called the intervention group) to the results of patients
who were offered the intervention without funding support or the contract requirement
(called the comparison group). Patients in both groups were referred by their physician or
self referred. Archived data from patient medical records was reviewed and analyzed. We
included male or female patients, 21 to 75 years of age with BMI of >30 kg/m2. The
intervention group was offered funding for a wide spectrum of treatment classes except
$25 material fee per 8 week class (total of $75) and signed an agreement to attend weekly
treatment sessions for 26 weeks. This group also was asked to complete five
questionnaires addressing psychosocial factors (Weight Loss Behaviors Perceived to be
Important, Frequency of Engaging in Specific Behaviors, Social Readjustment Rating
Scale, and The Hassles and Uplifts Scale). The comparison group was not offered the
funding support or contract, and chose the frequency and type of intervention sessions
depending on their willingness to pay and attend the treatment sessions. Assessments at
baseline and end of follow-up (weeks 0 and 26) include demographic, anthropometric.
lifestyle, and co-morbidity measures. During the programs, the number of therapy
sessions attended, adjunctive medication use, and supplemental diet products purchased
were assessed. The main outcomes were percent change in weight, BMI, and waist
circumference.
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Results: There were 23 men and 104 women in the intervention group (total
N=T27; mean BMI=40.5 ±8.7 (SD) and 36 men and 118 women (total N=154; BMI=
39.3±7.1 (SD) in the comparison group. Both groups experienced significant decrease in
weight (7.60 kg, or 6.68% from baseline for the intervention group vs. 6.23 kg or 5.84%
for the comparison group) at 26 weeks using intent-to-treat analysis. Those who started
with higher weight (pO.OOOl), attended more sessions (p=0.0050) and used adjunctive
weight loss medication (p=0.0144) lost more weight. There was no significant difference
in percent weight loss (p=0.7686) and percent change in BMI (p=0.7686) between the
intervention and comparison groups.
In the intervention group 100 of 127 (79%) participants completed the
questionnaires. Multiple regression models showed that of five psychosocial and
behavioral measures only frequency of engaging in weight loss-promoting behavior (self
monitoring, diet, and physical activity) (p=0.0455) were significant and independent
predictors of weight loss after adjusting for baseline weight. Major life change events,
frequency and intensity of daily positive and negative events (uplifts and hassles), and
perceived importance of weight loss promoting behaviors did not predict outcomes.
Discussion: We found that both weight management programs successfully
promoted significant weight loss (>5%) over a period of 26 weeks. The program that
offered a financial incentive and required an attendance contract did not promote greater
weight loss than a comparison program, but several predictors of success were identified.
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CHAPTER 1
INTRODUCTION

A. Statement of the Problem
Obesity is a complex chronic disease that develops over years or decades. There is
an urgent need to identify treatment approaches that may contribute to weight loss
success. In the absence of genetic change, the increase in weight is attributed to
behavioral, psychosocial, and environmental factors such as diet, exercise, stress, and
other lifestyle pattern changes (Flegal, et al., 2001; Hill, et ah, 1998). Most weight
management programs focus on reducing caloric intake. However, it is clear that energy
restriction alone is not sufficient. Predictors of weight management outcomes have been
examined in the past (Brownell, 1984; Foreyt & Goodrick, 1991). These studies have
concluded that predicting weight loss with certainty is difficult and complex. Potentially
many factors are involved contributing only a fraction in the change in weight making it
difficult to build a single predictive model (Foreyt & Goodrick, 1995; Weiss, 1997).
While few dispute the need for weight loss, it is important to identify factors
associated with successful weight loss. These factors could include adjunctive therapies
to dietary change (Astrup, et al., 2000; Jeffery, et al., 1993; Rolls, et al., 2002; Yu-Poth,
et al., 1999), including increased physical activity (Ballard & Poehlman 1994; Jeffery, et
al., 1984; Wadden, et al., 1997; Wing, 1999), increased intensity with more frequent
intervention sessions (Butsch, et al., 2007; Jeffery, et al.,1993); financial incentives
(Giuffrida & Torgerson, 1997; Janz, Becker, & Hartman, 1984; Kane, Johnson, Town, &
Butler, 2004); contracting (Neal, 1991); use of adjunctive weight loss medication

1

(Stafford & Radley, 2003; Wirth & Krause, 2001) and supplemental diet products
(Jeffery, et al., 1993).
Behavioral and psychosocial factors could also influence the success of weight
loss. Pre-treatment levels of perceived importance of engaging in weight loss enhancing
behaviors (Becker, et al., 1975); social support (Wing, 1999); behavior therapy (Wadden
& Foster, 2000); actual engagement in weight loss enhancing behaviors (Wadden, 1993;
Wadden, et al., 1992; Wing, 2003); major life events (Homes & Rahe, 1976); and levels
of daily hassles and uplifts (DeLongis, Folkman & Lazarus, 1988) could act as modifiers
of health outcomes. We have utilized five different psychosocial and behavioral
questionnaires to predict participant response to a medically supervised weight
management program.
Many point to high out-of-pocket costs as a barrier to treatment (Bryant, 2001;
Federal Trade Commission, 2006) since insurance coverage of obesity treatment is
patchy in the U.S. (Tsai, Ash, & Wadden, 2006). Some studies have shown that financial
incentives improve the effectiveness of obesity treatment programs (Hubbert, et al., 2003;
Jeffery, Gerber, et al., 1983; Jeffery, Bjomson-Benson, et al., 1984) showed that among
participants in a weight loss program, those receiving modest financial incentives (50%
of a $300 weight loss program fee if participants attended 10-12 sessions and lost 6% of
their initial body weight) had significantly higher chances of attending the recommended
number of sessions and achieving successful weight loss. However, in meta-analysis the
use of financial incentives did not promote successful weight loss or maintenance (PaulEbhohimhen & Avenell, 2008).
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Failure to attend the required intervention sessions may be associated with failure
to complete the treatment regimen or follow prescribed lifestyle changes and as a result, a
failure to achieve weight loss benchmarks. A systemic review of medically supervised
proprietary weight loss programs have shown 19-56% dropout rate during 26 weeks of
treatment (Tsai & Wadden, 2005).
The World Health Organization (WHO) reports that for diseases associated with
lifestyle, poor adherence to treatment is associated with worse health outcomes (WHO,
2003). Effective strategies need to be developed to improve patient adherence (Haynes,
2008). A written or verbal contract asking the patient to commit to adhere to the
prescribed set of treatment components may improve patient adherence and overall
outcomes (Bosch-Capblanch, et ah, 2009; Neale, 1991).
Environmental factors (Price & Gottesman, 1991; Stunkard, et ah, 1990) and
unhealthy lifestyle behaviors (Flegal, et ah, 2001; Hill, et al., 1998) could lead to
stressors that greatly impact the homeostasis of the body (Table 1). When exposed to
stress, the brain’s control center, the hypothalamus and brain-stem, stimulates neuronal
circuits and endocrine pathways, leading to elevation of glucocorticoid levels. Under
chronic exposure this can lead to behavioral and metabolic alterations which can increase
energy intake and decrease energy expenditure, resulting in obesity (Tsigos & Chrousos,
2002). Major life events and the readjustment required to cope with changes have been
correlated with increased risk of conditions such as obesity (Dohrenwend &
Dohrenwend, 1974). This approach is based on the premise that major life changes lead
to high levels of stress, which combined with inadequate coping skills can lead to chronic
detrimental health outcomes (Holmes & Rahe, 1967). Thus a life event scale might be a
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useful tool to assess the level of stress an individual is experiencing, possibly leading to
overeating, weight gain, and subsequent health problems. In addition, daily negative
events, or hassles, have been found to have an even greater impact on stress than major
life events (Kanner, et ah, 1981). Persons exposed to daily hassles such as irritating
encounters, frustrations, or work pressures may experience negative health outcomes as a
result of neurohormonal changes. This in turn increases stress, which may lead to less
compliance with a weight loss regimen and limited success. In contrast, daily positive
experiences such as social events and supportive encounters with friends and family
(uplifts), may help to counter the effects of hassles, reducing stress and the risk of illness.
Individuals with greater proportion of uplifts to hassles might be in a better position to
achieve successful weight loss (see Figure 1.1).
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B. Purpose of the Study
In 2007, the Institute of Medicine (IOM), reported identifying effective obesity
management strategies was an essential priority, with evaluations of weight loss
programs an important means of contributing to the evidence base (IOM, 2007).
In spite of an abundant body of literature on obesity, it is difficult to predict the
outcomes of clinically-based weight-loss programs (Baker & Young, 2006). Bish et ah,
(2005) discovered that 46% of women and 33% of men in the U.S. reported trying to lose
weight in 2000. Despite efforts to lose weight by a large majority of the population, many
people are unable to prevent or reverse obesity. This calls for developing new solutions to
confront the heart of the obesity epidemic (Blackburn & Waltman, 2005).
The National Heart, Lung, Blood Institute (NHLBI) defines successful long-term
weight loss as an intentional reduction of 5-10% from baseline maintained for one year.
Such weight loss, though modest, improves a host of cardiovascular risk factors
(Blackburn, 1995; Goldstein, 1991; Oster, et al., 1999), prevents the development of type
2 diabetes, and is achievable in clinical practice. Clinical guidelines from The National
Institutes of Health (NIH, 1998) indicate that decreased caloric intake, moderate physical
activity, and behavioral therapy constitute vital elements of any effective weight loss and
maintenance program. Furthermore, multidisciplinary programs that focus on positive
life '.tyle change and include expertise in health education, nutrition, exercise and
behavior change are recommended.
Lite-Weighs is a medically supervised, multidisciplinary weight loss program
located in Redlands, California. The program serves overweight, obese, and morbidly
obese patients who are self referred or physician-referred. The program focuses on health
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education, lifestyle skills development, behavior modification, nutrition, and physical
activity. Lite-Weighs also provides options for diet supplements and medications to
enhance weight loss.
In this study, we set out to investigate whether an intensive weight management
program that included funding support to offset expenses and a client attendance contract
was associated with clinically significant weight loss in obese and morbidly obese
patients compared to one which contained all other program components but did not
provide funding or require a contract. We also attempted to identify behavioral or
psychological factors associated with successful weight loss.
C. Research Questions
When comparing patients who participated in a 26-week weight loss program
which offered financial support for most program expenses and a participation contract
(the intervention group) to patients who constructed and paid for their own program
without a participation contract (the comparison group):
1. Were intervention group participants more successful in percent change in weight
or BMI than the comparison group at 26 weeks post intervention?
2. For either intervention or comparison, was the percent change in weight or BMI

associated with the quantity of supplemental diet products purchased?
3. For either intervention or comparison, was the percent change in weight or BMI

associated with the number of weekly sessions attended?
4. Was the percent change in weight or BMI associated with use of adjunctive

weight loss medication?
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Among patients who contracted to participate in a 26-week intervention with
financial assistance for program expenses and a participation contract (the intervention
group):
1. Did pretreatment level of perceived importance of healthy lifestyle behaviors
(self-monitoring, eating, physical activity) at baseline predict successful weight
loss?
2. Did pretreatment level of engagement in weight loss promoting lifestyle behaviors
(self-monitoring, eating, physical activity) predict successful weight loss?
3. Are baseline scores for major life change events and daily hassles vs. uplifts
associated with successful weight loss?
D. Theoretical Justification
Effective weight management strategies are linked to the concept of energy
balance. Obesity develops as a result of a cumulative excess of energy intake compared
to energy expenditure. To remedy this imbalance, a person should reduce energy intake
while increasing energy expenditure. Effective weight loss interventions should focus on
developing the skills necessary for adopting and maintaining healthy lifestyle behaviors,
leading to negative energy balance and improved health outcomes. Such interventions
should include diet therapy, physical activity, and behavior therapy with or without
pharmacotherapy (NHLBI, 1987).
Patients sometimes do not follow, or adhere to, recommended changes in diet,
exercise, and behaviors. Adherence is the degree to which a patient’s behavior (such as
eating and exercise) coincides with treatment guidelines (Evangelista, 2000). Poor
adherence to treatment (i.e., number of sessions attended) may be due to difficulty in
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changing entrenched personal habits, compromising the success of a weight management
program. One intervention strategy that could improve adherence is a contract between
the health care provider and the patient, in which both parties commit to a set of
treatment features that lead to successful weight loss.
A theoretical model that can be utilized to improve compliance or adherence to
weight loss treatment is called concordance theory. Concordance implies that patients and
practitioners formulate a mutually agreed upon plan of care which respects the wishes of
the patient (Jones, 2003). In this model, patients and providers act as partners to reach an
agreement on treatment strategies (Cox, 2004). This process can help health care
providers identify and address potential difficulties in treatment adherence (Townsend,
2003), ensuring that what has been agreed upon takes place and improves the likelihood
of weight loss success. However, most contracts depend on a relationship model in which
the health care provider designs a contract which places the responsibility of failure
solely on the patient rather than as a shared outcome. Stevenson (2000) argues that unless
patients and healthcare providers are mutually involved in the decision making process
on developing a plan of care, there is no basis of agreement on the treatment. Creating a
contract based on consensus between the patient and interventionist may enhance the
likelihood of program success.
Another explanation for weight loss efforts could be provided by psychology and
behavioral economics (Cawley & Price, 2009). The benefits of weight loss also may not
be immediate. Improvements in obesity related health risks as well as social and
economic disadvantages may not materialize for some time after weight loss (Ainsline,
1975). In addition, time-inconsistent preference (focusing on short-term interests instead
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of long-term benefits) by patients may lead to repeated failure at weight loss. Some
people can undercut their long range goal of weight loss by remaining in established
maladaptive habits such as over eating and sedentary lifestyle. Decision making becomes
a battle between farsighted planning and shortsighted actions (Thaler & Shefrin, 1981).
High out-of-pocket costs may also be a barrier to enrolling in treatment programs and
completing the recommended regimens.
Intervention programs that include financial support may provide a remedy to the
problems of lack of financial resources, saliency, immediacy and time-inconsistency of
weight loss. The amount and duration of financial support and the reasons for its use are
clearly delineated. Financial support may also help people to stay committed to the long
term goal (preference) of weight loss, especially if receiving the funds makes patients
more committed to program adherence (Laibson, 1997).
We hypothesize that an intensive intervention with financial support for program
costs may allow for a more effective dose of intervention by easing the financial burden
and allowing patients to participate in more frequent intervention sessions. Adding the
contractual agreement could further help improve patient program adherence by
increasing frequency of provider encounters, monitoring participant progress, and
adjusting the program to increase effectiveness. However, comparison group participants
did not have financial support and were not required to sign a contract, paying for
sessions based on their financial capacity. This precludes mandatory participation in
weekly sessions, possibly decreasing program effectiveness and weight loss.

9

E. Significance to Preventive Care
Obesity is a significant public health problem, affecting a substantial number of
people in the U.S. and other nations. Obesity is a major contributor to preventable
lifestyle related diseases and premature death. Understanding intervention strategies for
weight loss and identifying successful programs and the factors that contribute to their
effectiveness will enhance the ability of both clinical and population health professionals
to mitigate the devastating effect of the disease. The success of an obesity intervention is
influenced by both physiological mediators and psychosocial variables. Attitudes (beliefs
or feelings) about the importance of each behavior that will contribute to weight loss
success and the baseline frequency of engagement in these behaviors may be used to
better understand successful weight loss. Major life event changes and daily negative and
positive experiences (hassles and uplifts) may impact the neurohormonal pathways that
leading to stress and health conditions such as obesity. Preventive care specialists (PCS)
employ therapeutic lifestyle interventions to help patients develop the coping skills
necessary to reduce the prevalence of obesity and its health risks. As the prevalence of
obesity continues to increase, so does the number of people seeking the help of weight
loss programs and preventive care specialists. There are increasing numbers of
commercial weight loss programs on the market, but few have been evaluated for their
effectiveness, a necessary part of providing evidence-based intervention. Findings from
this study may provide preventive care specialists with the necessary knowledge and
skills to help them better educate and treat overweight and obese persons, thus lessening
the pervasiveness of obesity and limiting its associated health risks.
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CHAPTER 2
REVIEW OF LITERATURE

A. Overview
The prevalence of obesity and overweight among adults has increased markedly
over the last three decades, reaching epidemic proportions in the U.S (Figure 2.1).
Obesity is defined as body mass index of 30kg/m2 or greater and overweight is defined as
BMI greater or equal to 25kg/m2. Obesity and overweight varies by age, sex, and ethnic
group (Figures 2.2 & 2.3). Evidence suggests that obesity trends will continue to rise
(Ogden, et ah, 2006; Wang & Beydoun, 2007; Wang & Zhang, 2006).
The current high prevalence of overweight and obesity is likely due to a
combination of genetics and environmental interaction, in which already genetically
vulnerable individuals respond to environments with an abundance of energy rich,
calorically-dense foods coupled with limited opportunities for energy expenditure.
Today’s low cost, high-calorie, readily available diets, combined with energy saving
technological advances have promoted a lifestyle that increases the risk of being
overweight or obese (Pi-Sunyer, 2002).
Overweight and obesity represents a major public health problem, leading to
increased incidence of various health conditions such as diabetes mellitus, cardiovascular
disease, non-alcoholic fatty liver, gallbladder disease, stroke, osteoarthritis, and increased
risk of disability (Wolk, et ah, 2003). It is also linked to increased risk of all cause
mortality.
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Figure 2.1 Trends in Overweight, Obesity, and Extreme Obesity Among Adults Aged
20-74 Years: United States, 1960-2008 (CDC/NCHS, National Health Survey Cycle I,
1960-1962; National Health and Nutrition Examination Survey I, 1971-1974; Survey II,
1976-1980; Survey III, 1988-1994, 1999-2000, 2001-2002, 2003-2004, 2005-2006, 20072008).
Age-adjusted by the direct method to the year 2000 U.S. Census Bureau estimates, using
the age group 20-39, 40-59, and 60-74 years. Pregnant females were excluded.
Overweight is defined as a body mass index (BMI) of 25 or greater but less than 30;
obesity is a MBI greater than or equal to 30; extreme obesity is a BMI greater than or
equal to 40.
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B. Assessment of Adult Overweight and Obesity
In the past, health professionals used various methods of assessing and defining
overweight and obesity. Some measures are based on the relationship between height and
weight, while others depend on the measurement of body fat. According to the
Metropolitan Life tables, overweight was defined as a body weight greater or equal to
20% of the midpoint of the weight range for a medium size frame.
Today, the body mass index (BMI) is the most frequently used method, derived
by dividing an individual’s weight in kilograms by height in meters squared. The formula
is weight (kg)/height (m2). To obtain BMI using pounds and inches, multiply weight in
pounds by 704.5, divide the result by height in inches, and then divide the result by
height in inches a second time (NHLBI, 1998). The expert panel convened by the NHLBI
with the participation of the National Institute of Diabetes and Digestive and Kidney
Disease (NIDDK) and the National Institutes of Health (NIH) defined overweight as a
BMI between 25.0 and 29.9 kg/m2; obesity is defined as a BMI greater than or equal to
30kg/m2, and morbid obesity is defined as a BMI greater or equal to 40kg/m2 or 35 or
greater with co-morbidities (NHLBI, 1998).
Weight classifications based on BMI vary by sex, age, ethnicity, and other
variables (Baumgartner, et al., 1995). In general, women have more body fat than men,
due to less muscle and bone mass. In women the larger percentile of fat is stored in
subcutaneous tissue, while men tend to have fat deposits in visceral tissue. This pattern
of difference in body composition results in an unequal proportion of body fat at a given
body weight for men and women (Lemieux, et ah, 1993). At the same BMI, an older
adult person tends to have a higher body fat composition compared with younger
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individuals. Therefore, a given value of BMI may represent different percentages of body
fat and present different degrees of risk for obesity and other diseases (Ogden et ah,
2006).
C. Health Consequences of Obesity
/. Hypertension
There is consistent epidemiologic data linking obesity and hypertension
(Kannel, et ah, 1967). Jones, et ah, (1994) showed that in some populations, an almost
linear correlation exists between BMI and systolic/diastolic blood pressure. Many crosssectional studies have shown an association between hypertension and obesity. The
Framingham Study demonstrated that the risk of developing hypertension increases with
obesity. For every 10% increase in relative weight in men, systolic blood pressure
increased by 6.5mm Hg. The study also suggested that 65% of the risk for hypertension
in women and 78% in men could be related to obesity (Garrison, et ah, 1987). In the
Nurses’ Health Study, the relative risk for acquiring elevated blood pressure over a 16year period increased from 1.0 for a BMI <23 to 1.67 for BMI 23-25, to 2.8 for BMI 2628, to 3.86 for BMI of 29-31 and to 5.70 for BMI> 32 (Colditz, et ah, 1990; Carey, et ah,
1997). The association between obesity and hypertension is also confounded by various
factors including race, gender, genetics, and other demographic factors. The pattern of fat
distribution and type of obesity, especially increased visceral fat, is strongly associated
with hypertension. Excess body weight damages the capacity of the heart to function
properly, resulting in high blood pressure with potentially significant damage to the heart
and other organs (Pi-Sunyer, 2009). Stevens, et ah, (2001) found that severe hypertension
is improved or even eliminated with weight loss.
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2. Diabetes Mellitus
Overweight and obesity are among the strongest risk factors for type 2
diabetes. Obese individuals can develop a resistance to insulin, a hormone that regulates
blood sugar levels. After compensatory mechanisms by the pancreas are overcome, high
blood sugar levels damage the body. Extensive epidemiological evaluations have
indicated that obesity is independently related to the risk of acquiring type-2 diabetes
(Wing, et ah, 2001). Data from the Nurses’ Health Study show that as obesity levels
increase the risk of developing type 2 diabetes also increases (Carey, et ah, 1997; Colditz,
et ah, 1990). In individuals at high risk for type 2 diabetes, weight loss may help prevent
or delay the onset of the disease (CDC, 1997; Strum & Wells, 2001). Weight loss also
has been shown to reduce insulin resistance and enhance glycemic control (Maggio & PiSunyer, 1997;NHLBI, 1998).
3. Cardiovascular Disease
An American Heart Association report indicates that obesity is associated
with cardiovascular disease (CVD), (Alpert, 2001; Klein, et ah, 2004; Pascual, et ah.
2003). The Nurses’ Health Study demonstrated an association between obesity and CVD
(Manson, et ah, 1995). The study also showed that relative risk of CVD death rose
significantly with higher BMI (p < 0.001). In addition, the waist-hip ratio had a predictive
risk of CVD death of 8.7 compared to those in the lowest quintile. Other epidemiologic
data consistently show that CVD is associated with the duration and severity of obesity
(Pascual, et ah, 2003). These cardiovascular ailments include increased blood volume and
cardiac output and decreased peripheral vascular resistance (Alpert, 2001; Kasper, et ah,
1992), leading to elevated ventricular filling pressure, increased vascular wall stress,
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diastolic dysfunction, and an enlarged left ventricle (Contaldo, et al., 2002; Kasper, et al.,
1992; Ku, et al., 1994; Messerli, 1986). Studies have shown weight loss can improve
cardiovascular function and health (Alaud-din, et al., 1990; Alpert, et al., 1985).
4. Metabolic Syndrome
Metabolic syndrome is defined by multiple risk factors including central
adiposity, low HDL levels, hypertension, high serum triglyceride levels, and impaired
plasma glucose levels (Bary & Bellanger, 2006). Obesity and overweight are
components of metabolic syndrome.
5. Orthopedic Disease
The excess weight placed on the joints, especially the knees and hips,
result in rapid deterioration and wear and tear, causing pain and inflammation. Excess
weight also affects the spinal column, resulting in degenerative disc disease and bone
fractures (Creamer, 1997).
6. Respiratory Problems
Obese individuals are at high risk of developing obstructive sleep apnea
(Wolk, et al., 2003). Several cross-sectional studies have consistently reported a link
between obesity and the risk of sleep disorders (Young, et al., 2002). A significant
proportion (40%) of obese people experience sleep apnea and about 70% of people with
sleep apnea are also found to be obese (Vgontzas, et al., 1994). Other population-based
studies showed that a 10% weight gain was associated with a six-fold increase in the odds
of developing sleep apnea (Peppard, et al., 2000). According to a recent review by
Romero-Corral (2009) there is also an association between the severity of obstructive
sleep apnea and the extent of weight gain. Accordingly, weight loss has been shown to be
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associated with a decrease in breathing problems. Several other case-control studies
indicated weight loss in sleep apnea patients led to a significant decrease in apnea
frequency (Schwartz, et ah, 1991; Smith, et al., 1985). The mechanisms are thought to
involve fat deposition on the airway such as increased tongue and neck tissue in tongue
and neck causing the narrowing of the airway passage, which leads to intermittent
obstruction of the air flow (Schwartz, et al., 1991). Sleep apnea leads to wakefulness,
daytime drowsiness, and headaches. Increased weight also places a burden on the
thoracic cavity.
7. Gastrointestinal Reflux
Chronic pressure on the valves of the gastroesophageal junction weakens
the valves and result in the back flow of gastric acids into the esophagus. This reflex
causes symptoms of heartburn and indigestion. If left untreated, approximately 10-15%
of patients develop a pre-malignant change in the lining of the esophagus called Barrett's
esophagus, a pre-cursor of esophageal cancer (Sharma, 2004). Hampel et al., (2005) who
conducted a meta-analysis of nine studies regarding the association of obesity and the
risk for gastroesophageal reflux disease (GERD) and its complications, found a
statistically significant increase in the risk for GERD symptoms, erosive esophagitis, and
esophageal adenocarcinoma.
8. Depression
Morbidly obese patients face constant psychosocial challenges. Emotional
disturbances may result from repeated failed attempts at dieting and the inability to
maintain an ideal body weight. Other factors that lead to depression include disapproval
by family and friends, remarks from complete strangers, discrimination at the work place
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and inconveniences in public accommodations such as theater, airplane or bus seating
(Simon, et al., 2006; Stunkard, Faith, & Allison, 2003).
9. Cancers
Overweight and obese individuals are at an increased risk for developing
many cancers. An expert panel from the International Agency for Research on Cancer
(IARC, 2002) concluded that some colon cancers, breast cancers, endometrial cancers.
kidney cancers, and adenocarcinomas of the esophagus may be associated with adiposity.
Recent studies suggested that more cancers including adenocarcinoma of the gastric
cardia, gallbladder, liver, pancreas and prostate are associated with obesity and
overweight (Calle, 2007; Calle & Kaak, 2004). According to American Cancer Society
(ACS, 2002) estimates for cancer incidence, 51% of all new cancers among women in
2002 were linked to obesity. When analyzed to examine the association with different
types of cancer the report indicated that 2% of thyroid cancers (15,800 new cases), 6% of
uterine cancers (39,300 new cases), 12% of colorectal cancers (75,700 new cases), and
31% of breast cancers (203,500 new cases) among women were attributed to obesity risk.
Among men, cancers linked to obesity comprised approximately 14% of new cancers:
3% of kidney cancers (19,100 new cases) and 11% of colorectal cancers (72,600 new
cases), (ACS, 2002). In general, the mechanisms underlying the obesity and cancer link
are not fully understood. The available evidence for mechanisms linking obesity and
cancer risk involves the metabolic and endocrine effects of obesity and the alteration they
create in the production of peptide and steroid hormones (Calle & Kaaks, 2004). With
mounting evidence to support such an association it is important to recommend
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maintaining a reasonable weight for its multiple health benefits, including decreasing the
risk of cancer.
10. Mortality
Lew and Garfinkel (1979) showed that all-cause mortality has increased
due to increase in body weight. The Nurses’ Health Study findings indicated obesity and
mortality due to any cause had a J-shaped association; that is, women with lower BMI
had lowest mortality while those with higher BMI saw a steady increase in mortality
(Manson, et ah, 1995). According to the American Cancer Society (2002), obesity-related
cancers among women are estimated to comprise 28% of cancer-related deaths in 2002:
15% of breast cancers (39,600 deaths), 2% of uterine cancers (6,600 deaths), and 11% of
colorectal cancers (28,800 deaths). Among men, obesity-related cancers are estimated to
comprise 13% of cancer-related deaths in 2002: 10% of colorectal cancers (27,800
deaths) and 3% of kidney cancers (7,200 deaths).
D. Social Implications of Obesity
In a society that greatly values physical appearance and often associates
likeability and attractiveness to slenderness, the resulting emotional burden for those who
are obese can be overwhelming. Based on perceptions that they are lazy and insatiable.
overweight and obese persons may be subjected to discrimination and prejudice among
peers, at work, or other situations (Wellman & Friedberg, 2002). Rand and Macgregor
(1991) examined self-perceptions among individuals who successfully maintained weight
loss following a gastric restrictive surgery. The participants in their study viewed their
previous state of obesity as extremely distressful. They also preferred normal weight
over a major handicap such as deafness, dyslexia, diabetes, blindness, very bad acne,
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heart disease, or limb amputation. They would choose to be poor and slim than wealthy
and morbidly obese.
E. Economic Costs
The increase in the prevalence of overweight and obesity is also reflected in the
rising cost of related health problems. The total cost of overweight and obesity is $117
billion (Weight-control Information Network [WIN], NIDDK, 2006), of which $61
billion accounted for direct health care costs and $56 billion accounted for indirect health
care costs (WIN, 2006). Direct health care cost include preventive, diagnostic, and
treatment services related to overweight and obesity. Another study estimated annual
medical spending due to overweight and obesity alone (BMI>25) to be as much as $92.6
billion in 2002, corresponding to 9.1% of U.S. health spending (Finkelstein, Fiebelkom,
& Wang, 2003). The indirect cost category is reflected in the value of wages lost due to
poor health or disability and the value of future income lost due to premature death. The
effect on productivity related to overweight and obesity consists of workdays lost ($39.3
million), physician office visits ($62.7 million), restricted activity days ($239 million)
and sick days ($89.5 million) The cost of care associated with cardiovascular disease.
type 2 diabetes, and hypertension comprise the majority of these costs. Since the
prevalence of overweight and obesity has dramatically increased since 1995, the actual
costs are higher than the estimate provided.
F. Obesity Causes, Risks, and Contributing Factors
The causes of obesity are multi-factored and complex. Genes play an important
role in determining how individuals control calorie intake, metabolize it, and deposit the
excess calories. Environmental factors such as lifestyle and socio-cultural influences may
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play a significant role. People have become more sedentary, resulting in fewer calories
used than consumed. In addition, consumption of calorie-rich diets and total calories
consumed has increased overall.
/. Genetic Factors
Overweight and obesity may be a result of a mismatch between today’s
“obesogenic” environment and “energy-thrifty genes” that were designed to help our
ancestors conserve (deposit) energy in period of famine for later use. This function is
challenged by calorie-rich foods and less opportunity for physical activity. The variation
in how different individuals respond to the same environment suggests genes play a role
in the development of obesity.
The studies of resemblance and variation among twins and adoptees have
provided indirect evidence of the genetic basis of obesity. The weights of adopted
children did not show a correlation with the body weight of adoptive parents who
provided them with food and other needs (Stunkard, et ah, 1986; Sorenson, et ah, 1992).
On the other hand, even in cases in which adopted children never met their genetic
parents, their weight showed an 80% correlation with their biological parents. When the
weight of identical twins was compared to that of fraternal twins, the identical twins
showed more similarity than the fraternal twins (Allison, et ah, 1994; Allison, et ah,
1996; Maes, Neal, & Eaves, 1997). Although a clinical link is not fully understood, there
are more than 250 genes, markers, and chromosomal regions that have been implicated
with human obesity (Rankinen, et ah, 2002).
Direct evidence for obesity genes are due to single gene mutations. These extreme
cases of obesity are rare and account for a small fraction of obese individuals. A mutation
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in a single Melanocortin 4-receptor gene that is related to the control of feeding behavior
has been found to be strongly associated with some obesity cases. The Human Obesity
Gene Map showed single mutations in 11 genes which were implicated in cases of
obesity. Fifty chromosomal locations relevant to obesity have been identified (Nirma,
et ah, 2008). Gathering family health history can provide health care specialists with
important information on genetic susceptibilities shared by relatives, identifying those at
high risk for obesity and obesity related disorders.
2. Environmental Factors
The strong influence of environment on the prevalence of overweight and
obesity has been suggested by epidemiological studies (Flegal, et ah, 1998). People of the
same genetic background may have different rates of obesity resulting from a difference
in their lifestyle. A study that compared the rate of obesity and other chronic disease
among Pima Indians who live in rural Mexico and practice a traditional lifestyle (eat
Pima diet and are physically active), with Pima Indians who live in live in the U.S. (are
sedentary and consume a Western diet) found that the rate of obesity is higher in the U.S.
Pima Indians (Ravussin, et ah, 1994; Zimmer, et ah, 1997). Even within the U.S.
population, environmental factors have changed over the decades, including easy access
to energy-rich, high-calorie food and the popularity of sedentary pastimes such as
television and video games (Hill & Peters, 1998). Intervention studies have suggested
that changing the unhealthful environment has a positive impact on modifying lifestyles,
improving desirable eating behavior, encouraging physical activity, and increasing
biological endpoints (Jeffery, 1995; Taylor, et ah, 1991; Winkelby, 1994). Pima Indians
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with a genetic predisposition to weight gain and living in an “obesogenic,, environment in
Arizona have difficult challenges to maintain a normal, healthy body weight.
3. Sedentary Lifestyle
The level of physical inactivity strongly influences obesity. A sedentary
life, defined as engaging in less than 30 minutes of moderate physical activity each day.
is strongly correlated with obesity and other preventable chronic diseases. The direct cost
of physical inactivity is estimated to be as high as $24.3 billion (Colditz, 1999). Physical
inactivity increases with age, is more common among females than males and among
those with lower incomes and limited education (CDC, 1999). In the U.S, only 26% of
adults engage in vigorous physical activity three or more times each week. That means
about 59% of adults do not engage in any vigorous physical activity during their leisure
hours (Lethbridge-Cejku & Vickerie, 2005). Jakicic, et ah, (1997) reported a positive
association between the amounts of exercise equipment at home and availability of
exercise facilities in the neighborhood with levels of physical activity among adults.
Adults living in homes or communities with greater access to exercise equipment were
more likely to engage in physical activity. Similar findings were reported for children
(Sallis, et ah, 1990). Physical activity helps to manage weight and decreases the risk of
developing and dying from various chronic diseases (Paffenbarger, et ah, 1993).
4. Eating Behaviors
Portion size, the specific amount of food an individual eats during a given
meal, is also a factor in obesity (Wellman & Friedberg, 2002). Although the U.S.
Department of Agriculture (USDA) provides a guideline for portion sizes in its Food
Guide Pyramid, most people eat in excess of the recommendations (USDA, 2011). A
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study by Cheadle (1995) found a strong correlation between fat intake and the grades of
milk and meat found in local grocery stores. In neighborhoods where the stores supplied
higher grades of milk and meat, people were more likely to consume larger amounts of
energy-rich fat. An individual’s preferences determine the types of food he or she eats;
people tend to eat what they enjoy. This is partially determined by innate and experience
factors (Drewnowski, et al., 1991).
5. Metabolism
Metabolic factors also are believed to contribute to the etiology of obesity.
Energy intake that exceeds total body energy expenditure ultimately results in weight
gain. Total energy expenditure includes resting energy expenditure (cellular processes
necessary to sustain life), the thermic effect of food, and physical activity related
expenditure. The relative contribution of each component differs, with about 10% coming
from the thermic effect of food, about 60% during rest, and the remaining 30% from
activity related expenditure. Genetics influence an individual’s resting energy
expenditure (Bogardus, et al., 1986; Bouchard & Tremblay, 1990), the thermic effect of
food (Bouchard & Tremblay, 1990) and adaptive body fat changes to overfeeding
(Bouchard, et al., 1990). Low total daily energy expenditure has been found to be
strongly associated with the rate of weight gain (Ravussin, et al., 1988). A study
conducted among Pima Indians found that reduced activity-related energy expenditure
may be a significant factor in developing obesity (Zurlo, et al., 1992). Activity related
expenditure is the most variable factor and accounts for about 30% of the total
(Carpenter, et al., 1995; Goran, 1995). Ravussin (1995) reported that the differences in
metabolic rates are important factors in developing obesity and individuals with lower
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metabolic rates had a greater incidence and magnitude of obesity. Energy intake and body
weight are also influenced by the central nervous system’s influence on metabolism
through its effects on behavior, on autonomic nervous system activity, and on
neuroendocrine system, including secretion of hormones (Spiegelman & Flier, 2001).
6. Medical Conditions
Certain medical conditions such as insomnia, hypothyroidism, depression,
eating disorders, Cushing’s disease, and polycystic ovary syndrome, and modifying
behaviors such as smoking cessation can increase the risk of weight gain. Some
medications such as antidepressants, corticosteroids, antipsychotics, antiepileptics, and
medications for hypertension and diabetes are also known to increase the risk of weight
gam.
Stress also is associated with being overweight or obese. Stress is linked to
environmental cues like major life changing events (i.e., divorce or death of a family
member) and more frequently experienced daily negative or positive encounters
("hassles and uplifts”). Selye (1956) and Moss (1973) hypothesized that the stress of
constantly adjusting to both major and minor life events takes a physical toll on the body,
including reduced resistance to disease.
Kanner et al. (1981) and DeLongis et al. (1982) found that minor but more
frequent stressors (hassles) have a more profound effect and are more predictive of health
outcomes than major life events. Stress cues parts of the brain, primarily the
hypothalamus, to initiate a neurohormonal pathway to coping with stress known as the
Hypothalamus-Pituitary-Axis (HPA), (Tsigos & Chrousos, 2002). When activated, this
pathway elevates cortisol in the blood, which inhibits other energy demanding pathways
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such as thyroid secretion, sex steroid production and growth inhibition, resulting in less
bone and muscle mass growth (see Figures 2.4 and 2.5), and an increase in visceral
adiposity (Chrousos, 1992; Tsigos, et al., 1994).
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Figure 2.4 A Simplified Schematic Representation of the Central and Peripheral
Components of the Stress System, Their Functional Interrelations, and Their Relations to
Other Central Systems Involved in the Stress Response (Adapted from Chrousos and
Gold, 1992). The CRH/AVP neurons and central catecholaminergic neurons of the
LC/NE system reciprocally innervate and activate each other. The HPA axis is controlled
by several feedback loops that tend to normalize the time-integrated secretion of cortisol,
yet glucocorticoids stimulate the fear centers in the amygdala. Activation of the HPA axis
leads to suppression of the GH/IGF-1, LH/testosterone/E2 and TSH/T3 axes; activation
of the sympathetic system increases IL-6 secretion. Solid lines indicate stimulation;
dashed lines indicate inhibition.
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Figure 2.5 Detrimental Effects of Chronic Stress on Adipose Tissue Metabolism and
Bone Mass (Adapted from Chrousos, 1998). G. P. Chrousos. Stressors, stress, and
neuroendoctrine integration of the adaptive response. The 1997 Hans Selve Memorial
Lecture. Ann NY Acad Sci, 85 J, pp. 311-335). Solid lines indicate stimulation; dashed
lines indicate inhibition.
7. Socioeconomic Factors
Disparities in socioeconomic status may contribute to the prevalence of
obesity in lower income groups. The income gap contributes to the differences in access
to healthy foods and opportunities for physical activity (Cheadle, et al., 1995; Hill &
Peters, 1998). Sobal and Stunkard (1989) reviewed 144 published studies on the
relationship between socioeconomic status (SES) and obesity. The authors reported a
strong inverse relationship between SES and obesity in western societies; women with
lower SES were far more likely to be obese (Sobal & Stunkard, 1989), though the
relationship was inconsistent for men and children. On the other hand, in developing
societies, a strong direct relationship was reported between SES and obesity among men,
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women, and children (Sobal & Stunkard, 1989). A review of social attitudes toward
obesity and thinness reveals values congruent with the distribution of obesity by SES in
different societies. Factors that influence attitudes toward obesity and thinness among
women in western societies include dietary restraint, physical activity, social mobility,
and genetics.
8. Cultural Factors
Different cultures view obesity as either desirable or undesirable. For example, in
North African countries obesity has become a growing problem, especially among those
with resources, since fatness and specifically female fatness is viewed as a sign of social
status and is a cultural symbol of beauty, fertility, and prosperity (Mokhtar, et ah, 2001).
In the U.S., studies indicate that obesity among Blacks and Hispanics is associated with
lesser preoccupation with weight control, lower likelihood of perceiving oneself as
overweight and related obesity tolerant behaviors and attitudes. These attitudes limit the
motivation for weight loss or effectiveness of weight loss attempts (Dawson, 1988;
Desmond, et ah, 1989; Hazuda, et ah, 1983; Kahn, Williamson, & Stevens, 1991;
Kumanyika, Wilson, & Guilford-Davenport, 1993; Rand & Kuldau, 1990). However,
cultures whose members equate thinness with beauty and health are more likely to weigh
less or seek to maintain a desirable body weight. Cultures also determine diet and
consumption patterns. In some cultures energy dense, fat-rich diets are preferred, creating
conditions for energy excess and obesity, while in others a more health conscious
approach is chosen.
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G. Obesity Management and Interventions
The NHLBI Obesity Education Initiative Expert Panel recommends an initial goal
for weight loss of up to 10% of baseline at the rate of 1-2 pounds per week. According to
the guidelines, prevention of weight gain with lifestyle is indicated for patients with a
BMI > 25kg/m2, even without comorbidities, and weight loss is recommended for those
with BMI of 25-29.9kg/m2 plus with two or more comorbidties or with BMI of >30kg/m2.
Pharmacotherapy is recommended for patients who fail to lose 1 pound per week after a
6-month trial of combined lifestyle intervention. Patients with BMI 27-29.9kg/m2 and
comorbidties or BMI >30 may benefit from drug therapy. Weight loss surgical
intervention can be an option for morbidly obese patients. Morbid obesity is defined as a
BMI>40 or BMI >35 with other risk factors or disease.
Strategies for weight management in overweight and obese adults have three main
components: dietary therapy, moderate physical activity, and behavioral therapy.
Moderate weight loss achieved through sustainable lifestyle modification can mitigate
some of the health risks associated with overweight and obesity. It takes most patients
about six months to achieve a new equilibrium of energy balance (NIH, NE1LBI, North
American Association for the Study of Obesity [NAASO], 2000). To achieve additional
weight loss after the initial six-month period, therapy goals must be revised to account for
the decreased energy requirement. The next phase of weight loss should target weight
maintenance. A regain of weight less than 6.6 pounds (3kg) in two years and a sustained
decline in waist circumference of at minimum 1.6 inches represents successful weight
maintenance.
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1. Diet Therapy
The objective of dietary therapy is to reduce the total amount of caloric
intake through diet modification. This can be achieved by creating a deficit of 500 to
1000 kcal/day, resulting in weight loss of 1 to 2 pounds per week. Low caloric diets
(LCDs), also called Step I diets, reduce caloric intake by 500-1000 kcal/day. For women,
diets containing 1,000-1200 kcal/day and for men 1200 to 1600kcal/day may be
appropriate.
The use of alcohol as a source of calories should be assessed and controlled. Total
fat intake should be limited to 30% or less of total calories, saturated fatty acids to 8-10%
of total calories, monounsaturated fatty acids up to 15% of the total calories,
polyunsaturated fatty acids up to 10% of total calories, and cholesterol <300 mg/day.
Protein derived from plant and lean sources of meat may be used to provide about 15% of
total calories. Fifty-five percent or more of total calories should come from
carbohydrates. Vegetables, fruits, and whole grains are excellent sources of
carbohydrates, vitamins, minerals, and fiber. The recommended amount of fiber is 20 to
30 grams per day. Diets rich in fiber may be effective in reducing serum cholesterol
levels and may promote weight loss and weight management by enhancing satiety at
lower level of caloric intake (Butrum, et al., 1988; U.S. Public Health Service [USPHS],
1988; American Diabetes Association [ADA], 1998). Salt should be limited to no more
than 100 mmol/day (approximately 2.4 g of sodium). Women who are at risk for
osteoporosis are recommended to take 1,000 to 1,500 mg of calcium per day.
Patients with high serum cholesterol levels can be advanced to a Step II diet to
further reduce LDL-cholesterol levels. In Step II diets, all nutrients are the same except
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for saturated fats, which are reduced to fewer than 7% of total calories and cholesterol
levels, which are limited to less than 200 mg/day. Very low calorie diets (VLCDs) are
defined as less than 800 kcal/day and may be used in limited circumstances. Patients
enrolled in a VLCD require supplementation and monitoring by trained staff (NHLBI,
NIH, NAASO, 2000).
2. Physical Activity
The practical guidelines by the NHLBI (2002) recommend moderate
levels of physical activity for 30 to 45 minutes on most and preferably all days of the
week. This represents an expenditure of approximately 150 calories of energy per day or
1000 calories per week. Successful weight management programs make physical activity
a vital part of their intervention (CDC, 2008). Although physical activity might not lead
to more weight loss compared to diet alone, it helps in preventing weight regain (Pate, et
al., 1995; NIH, 1996). Individual preferences should be considered when choosing the
type of physical activity. Duration, intensity, and frequency can be adjusted to make
physical activity a lifelong behavior.
3. Behavior Therapy
Often, individuals who are overweight or obese face barriers that hinder
compliance with intervention. Behavior modification techniques such as self-monitoring,
stimulus control, cognitive restructuring, goal setting, and relapse prevention can be used
to help individuals change behaviors that contribute to being overweight or obese and
adopt new dietary and physical activity behaviors that lead to weight loss (Wadden &
Foster, 2000).
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Self-monitoring involves recording and monitoring targeted aspects of behavior
that impact weight loss, such as eating habits, daily weighing, exercise, or the measured
outcome of the behavior such as weight lost, waist circumference, or other biomedical
variables. This systematic accounting will lead to increased awareness of both desirable
and undesirable behaviors, making it easier to review and adjust behaviors to achieve that
goal. When a planned behavioral goal is met, the person may receive a reward that is
desirable, timely, and consistent with achieving the goal.
Stimulus control involves recognizing environmental or socio-cultural cues that
encourage the undesired behavior and then making an effort to modify those cues.
Weight loss efforts are often subverted by negative thoughts and beliefs.
Cognitive restructuring skills help to identify and modify such distorted feelings by
raising awareness, and eliminating or replacing them with positive and desirable thoughts
that enhance the outcome of weight loss and maintenance (Wadden, et ah, 1993).
Defining a specific, measurable, and achievable goal through realistic actions and
behaviors helps achieve the desired amount of weight loss. In most cases 5-10% of initial
weight loss at the rate of 1-2 lbs is recommended as a physiologically beneficial and
achievable amount of weight loss (NIH, 1998). Patients set goals for calorie intake, diet
composition, physical activity and other modifiable variables.
Relapse prevention teaches individuals to anticipate and cope efficiently with
risky situations where relapse to a maladaptive habit is most likely to occur. This is
accomplished by first identifying those factors that pose the greatest risk for relapse;
second, by evaluating the processes that may have led to prior to the relapse; third, by
assessing the reaction to the relapse and the extent to progression to full-blown relapse;
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fourth, by strategies planned to intervene to prevent or manage relapse episode; and
lastly, by learning from a relapse and developing more effective prevention skills
(Larimer, Palmer, & Marlatt, 1999; Marlatt, Parks, & Witkiewitz, 2002).
4. Adjunct Weight Loss Medication
Medications may be used as a part of program that includes diet, physical
activity, and behavior therapy in individuals with BMI > 30 or >27 with other obesity
related risk factors or disease. In the last two decades, many drugs were introduced and
others withdrawn from the market due to unacceptable side effects (Cannolly, et al.,
1997). However, in 1997 the Food and Drug Administration (FDA) approved
Sibutramine until it was recently removed from the market, and in 1999, Orlistat for long
term use. Selected patients may benefit from these long-term drugs to help reduce weight
regain and maintain weight loss. The weight loss attributable to drugs is variable from
person to person though the range is reported to be two to ten kilograms (4.4 to 22
pounds) loss.
Most of the drugs developed are appetite suppressants or anorexiants which
function by affecting neurotransmitters in the brain via catecholamines (dopamine and
norepinephrene), serotonin or by influencing a combination of these neurotransmitters.
Sibutramine works by inhibiting the reuptake of norepinephirine and serotonin. Others
work by modifying nutrient absorption from the GI tract. Orlistat is one such drug and
functions by blocking the absorption of one-third of the available fat. Phentermine,
Mazindol and others are approved for short-term use.
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5. Obesity Surgery
Morbidly obese patients (BMI>40 or a BMI >35 with obesity related
health risk) may benefit from bariatric surgery. Bariatric surgery provides medically
significant weight loss over time. Most patients achieve reversal of diabetes, control of
hypertension, improved mobility, fertility and overall improvement in quality of life.
Effective surgeries target restricting gastric volume, altering digestion, or both. Banded
gastroplasty and Roux-en-Y gastric bypass are surgical procedures in current use.
Some bariatric surgeries may have perioperative and postoperative complications.
Patients should be assisted in dealing with new energy requirements through guidance on
diet, physical activity, and psychosocial issues. Complications may include wound leak,
infection, organ injures, incision hernias, gallstones, dumping syndrome (rapid gastric
emptying which occurs when the undigested contents of the stomach are transported or
"dumped" into the small intestine too rapidly) or failure to lose weight. Deficiencies of
vitamin B12, and iron deficiency with anemia are some additional complications of
bariatric surgery. Flabby skin resulting from weight loss may be a source of emotional
distress for some bariatric clients. In restrictive operations, failure to lose weight may
result from failure to dietary compliance because high calorie intake is not prevented by
the narrow outlet. Late failure or dilation of the pouch can also lead to increased intake
and limited weight loss.
6. Financial Support
An explanation for weight loss failures could be provided by theory and
evidence from psychology and behavioral economics (Cawley & Price, 2010). The
physiological benefits of weight loss may not be readily apparent to the individual and
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goes unrecognized. Improvements in obesity related health risks, and social and
economic disadvantage may not materialize for some time after weight loss (Ainsline,
1975). In addition, time-inconsistent preference by patients (short-term gratification
outweighing long-term planning) may lead to repeated failure at weight loss. People
undercut their long range goal of weight loss by consistently failing victim to
maladaptive behaviors of over eating and sedentary lifestyle (shortsighted interests)
(Cawley & Price, 2010). Decision making becomes a battle between farsighted planning
and shortsighted action (Thaler & Shefrin, 1981). High out of pocket costs may also be a
barrier to enrolling in a treatment program and completing the recommended regimen.
There are high out of pocket costs involved in enrolling in weight loss programs
and this could be a barrier to treatment (Bryant, 2001; Federal Trade Commission, 2006)
as insurance coverage of obesity treatment is patchy in the U.S. (Tsai, Ash, & Wadden,
2006). Some studies have shown that financial incentives improve the effectiveness of
obesity treatment programs (Jeffery, et ah, 1983; Jeffery, et ah, 1984). Hubbert et ah,
(2003) showed that among participants in a weight loss program, those receiving modest
financial incentives (50% of $300 weight loss program fee if the participants attended 1012 sessions and lost 6% of their initial body weight) had significantly higher chances of
attending the recommended number of sessions and achieving successful weight loss. A
review of 42 studies of the economic effects on health behaviors such as exercise,
smoking cessation, and immunization by Kane et ah (2004) found that economic
incentives were associated with behavior change in 73% of the studies. A meta-analysis
of substance abuse treatment programs found that financial incentives improved
compliance by an average of 30% (Fussier, et ah, 2006). However, another meta-analysis
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of nine randomized clinical trials (RCTs) that used financial incentives for weight loss
found that the incentives did not promote successful weight loss or maintenance (PaulEbhohimhen & Avenell, 2008).
7. Contracts
The World Health Organization (WHO) reports that for diseases
associated with lifestyle, poor adherence to treatment is associated with worse health
outcomes (WHO, 2003). Adherence is the degree to which a patient’s behavior (such as
eating and exercise) coincides with treatment guidelines (Evangelista, 2000). Sackett
(1979) reported that adherence in keeping appointments may be as low as 10%. Effective
strategies need to be developed to improve patient adherence (Haynes, 2008). A written
or verbal contract asking the patient to commit to adhere to the prescribed set of
treatment components may improve the patient’s adherence and overall outcome (BoschCapblanch, et ah, 2009; Neale, 1991).
Patients often do not follow recommended changes in diet, exercise and
behaviors. Poor adherence to treatment (i.e., number of sessions attended) may be due to
difficulty in changing entrenched personal habits. This could compromise the success of
a weight management program.
Concordance theory explains why it may be possible to improve compliance or
adherence to recommended treatment regimens and achieve weight loss (BoschCapblanch, et ah, 2009). The concordance model involves patients and practitioners
formulating a mutually agreed upon plan of care which respects the wishes of the patient
(Jones, 2003). Patients and providers work to reach an agreement on treatment strategies
(Cox, 2004). This process will help health care providers identify and deal with potential
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difficulties in adhering to treatment (Townsend, 2003), ensure that agreed-upon goals and
milestones are met, and improve the likelihood of weight loss success. It also reinforces
the mutual contribution of the patient and provider to a successful treatment (Maher,
2003).

A systematic review of strategies to improve adherence in general (Haynes,
2008), on tuberculosis treatment (Volmink, 2000, 2006), and HIV/AIDS treatment
(Rueda, 2006) reported the association of adherence with desirable health outcomes.
However, most health intervention contracts depend on a model in which the health care
provider designs the contract and places the responsibility of failure solely on the patient
rather than as a shared outcome. Stevenson (2000) argues that unless patients and health
care providers are mutually involved in the decision making process when developing a
treatment plan, there is no basis for reaching consensus on the treatment. Signing a
treatment contract based on mutual agreement between the patient and interventionist
may enhance the chance of program success.
Trials that addressed contract intervention for weight loss by Aragon, (1975)
found participants who signed a contract lost more weight than those in the control group.
Craighead (1989) reported that a supervised exercise group using contracts lost
significantly more weight than those in the minimal care group both at 12 weeks and 12
months. However, Murphy (1982) did not find a statistically significant difference in
weight loss between contracted and non-contracted groups. A study by Haber (1993)
examined the effect of an intervention that included contracts to reduce specific dietary
components, improve exercise, and manage stress. The contract group successfully
modified some aspects of their diet.
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H. Adult Obesity Treatment Program Outcomes
Although there are many weight management programs, the evidence
demonstrating their effectiveness is mixed. Thus a need for a systemic approach to
obesity management is essential for conquering obesity and improving the outcomes of
patients seeking intervention.
A meta-analysis of 12 dietary intervention-controlled trials on body weight
involving a total of 1,910 subjects reported that initiating an ad libitum low-fat diet
resulted in an overall 10.8% decrease in total calories consumed as fat and 272 kcal/d
decrease in energy intake as compared to control group (p=0.002) (Astrup, et ah, 2000).
Yu-Poth, et al., (1999) evaluated the results of 37 diet intervention studies involving
9,276 patients who were given the National Cholesterol Education Program's Step I or
Step II diets, which reduced energy intake from fat to <30%. The study showed that a 1%
decline in energy consumed from fat was associated with a 0.28kg weight loss. A study
that examined the result in weight loss at 6-months in five randomized clinical trials of
low-fat vs. low-carbohydrate diets among adults (Brehm, et al., 2003; Foster, et al., 2003;
Samaha, et al., 2003; Yancy, et al., 2003) reported that subjects randomized to lowcarbohydrate, high protein, and low fat diet achieved more weight loss at six months than
with the low fat diet alone.
Rolls, Morris, and Roe (2002) evaluated the effect of portion size on energy
intake and reported a linear relationship between the two. Jeffery, et al., (1993) examined
the effect of providing prepackaged meals with behavior change therapy on the success
of a weight loss program. The authors concluded that participants who were provided
with prepackaged meal replacements lost more weight than those prescribed only a self
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chosen diet. Wadden, et al., (1990) evaluated the impact of very-low-calorie diets
(VLCDs) and low-calorie diets (LCD) and found that VLCDs result in more weight loss
in short term than LCD, but in the long term the VLCD resulted in weight gain and the
total weight loss was similar for both groups.
Physical activity alone as a strategy for weight loss results in minimal weight loss
(Wing, 1999). When comparing modified diet therapy to a modified diet therapy plus
exercise weight loss does not appear to result in a significant difference in the short-term
(Bertram, et. al, 1990; Blonk, et. al., 1994). However, the relationship between physical
activity and weight loss maintenance is significant. Analysis of large cross-sectional case
studies and prospective trials found that regular exercise was associated with successful
long-term weight loss (Hartman, et al., 1993; Jeffery, et al., 1984; Kayman, et al., 1990;
Marston & Criss, 1984). Studies suggest moderate physical activity is associated with
successful long-term weight maintenance (Jakicic, et al., 1999; Jeffery et. al., 1998;
Schoeller, et. al., 1997; Wing & Tate, 2000). Anderson et al. (1999) compared the effect
of structured aerobic exercise programs and increasing daily lifestyle activities to be
effective in maintaining long-term weight loss. This suggests that changing lifestyle
activities is an acceptable alternative to programmed exercise for obese patients.
Providing patients with the skills, motivation, and support to change diet and
exercise behaviors in order to avoid adverse health patterns has an impact on modifying
health risks such as cardiovascular disease. A review of 29 trials with at least a one-year
follow-up found that average weight change in diet or physical activity group was 1.9 to
8.8kg with a mean 3.3kg weight loss (NHLBI Obesity Education Initiative, 1998).
Counseling for low calorie diet (1000-1200kcal per day) reduced body weight by an
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average of 8% from baseline over 3 to 12 months (NIH, 1996; Stevens, et ah, 2002). A
very low calorie diet produced the greatest weight loss but the outcomes were similar
after one year. A review of 24 randomized clinical trials also showed that counseling for
physical activity led to weight loss of 2-3% (NHLBI Obesity Education Initiative, 1998).
Greater weight reduction was achieved when a combination of diet, physical activity, and
behavior therapy was added as an adjunct modality (NIH, 1996). In a review of 24
studies of weight loss, when behavioral interventions were combined with diet or
exercise the interventions were effective over the long-term (-3kg) 12 to 60 months.
Another review by the Canadian Task Force on Preventive Health found that weight
reduction was most effective with supervised dietary treatment (Douketis, Feightner,
Attia, & Feldman, 1999). McTigue et al. (2003) identified 17 randomized clinical trials
of counseling and examined weight loss maintenance trials separately and found attrition
varied from 5-35%, with different rates of attrition for different treatments. Patterns of
enrollment, random sampling, and poor gender and ethnic diversity resulted in limitations
of the study outcomes.
Behavior therapy should involve developing specific realistic goals which can be
measured with plans to achieve those incremental goals and prevent setbacks. Data from
the National Weight Control Registry (NWCR) was analyzed for behaviors that were
associated with successful long-term weight loss (Klem, et al., 1997; McGuire, et ah.
1998; Wyatt et al., 2002). The study reported self-monitoring, low calorie intake, eating
daily breakfast, and engaging in a regular exercise as a major behaviors practiced by
those who had maintained successful weight loss.
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Medically supervised commercial programs include physician monitoring to
manage obesity related complications. Most of these programs use very-low-calorie diets
(<800 kcal/d) with high protein intake, 70 to lOOg/d to preserve lean mass. The VLCD
diets resulted in mean weight loss of 3 lb weekly (NIH, 1998). The complications include
elevated risk of gallstones, hair loss, cold intolerance, and change in bowel habits (NIH,
1993). OPTIFAST, Health Management Resources, and Medifast (Jason Pharmaceticals,
Inc., Owings Mills, MD) are reputable, medically supervised weight management
programs. The programs focus on meal replacements and lifestyle modification involving
12 to 18 weeks of rapid weight loss, followed by a 3 to 8 week transition phase and long
term maintenance program (OPTIFAST, Health Management Resources). Mandatory
medical monitoring is provided in the first two phases.
A randomized clinical trial aimed at assessing the efficacy of proprietary-based
programs involving meal replacement and other lifestyle interventions (Anderson, et ah,
1994) found at the end of 12 weeks participants who received meal replacements lost
15.3% of their initial weight, while those who followed conventional diets lost 14.1% of
their initial weight and maintained 8.4% in a one year follow up evaluation.
Multiple case series evaluations of OPTIFAST programs were conducted. One
study held at 18 sites involving 12 weeks of VLCD showed those who completed
treatment lost 21.8% of initial weight, compared with 11.3% for those who dropped out.
A one-year follow up of 43% of the original sample found that these participants
maintained a loss of 9% of their initial weight (Wadden, Foster, Letizia & Stunkard,
1992). Another single site OPTIFAST intervention study reported participants who
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completed the program lost 19.9% of their initial weight after a 26-week intervention
(Walsh & Flynn, 1995).
Similarly, a review of two case series of the Health Management Resources
program at a single center with 12-17 week intervention period reported that participants
lost 19.2% of their initial weight (Anderson, et ah, 1991). Another single-center Health
Management Resources study reported that morbidly obese participants who were treated
for 26 weeks lost 27% of their initial weight. The results of these medically supervised
commercial weight loss programs suggest that patients who complete a comprehensive
intervention program can expect to lose 15 to 25% of their initial weight during 3 to 6
months of treatment and may maintain a weight loss of 8% after one year (Anderson, et
ah, 1994; Flynn & Walsh, 1993). These studies also reveal that morbidly obese patients
lost the greatest percentage of their initial weight.
I. Conclusions
Contributing factors of obesity are both physiological and psychosocial. Attitudes
towards and level of engagement in behaviors that promote weight loss can provide a hint
about potential success of weight loss effort. Exposure to major life change events, daily
hassles and buffering positive uplifts act impact the severity of stress and other health
outcomes such as obesity. Providing coping skills and overcoming the burden of these
psychosocial parameters can predict success of weight loss.
Obesity treatment is challenging. It is the one of the most difficult and frustrating
health issues for patients and clinicians. An overwhelming amount of effort is spent on a
variety of intervention strategies with limited beneficial outcomes. The most successful
program results in about 8% weight loss. The absence of proven clinical success has

43

created an enormous demand for weight management resources. At any given time.
thousands of men and women are attempting to lose weight. It is necessary to continue to
investigate and identify factors and strategies associated with program success.
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CHAPTER 3
METHODS

A. Study Design
The study used secondary archived patient data from the Lite-Weighs medical
weight management program, operated by the Beaver Medical Group, to evaluate the
effectiveness of a comprehensive long term weight loss program for obese or morbidly
obese persons. Beaver Medical Group, an HMO type insurance plan, is prevention and
lifestyle oriented, encourages their patients to engage in positive lifestyle behaviors, and
offers them programs to support such choices if medically indicated. All variables were
abstracted from the Beaver Medical Group patient database. The study focuses on the
analysis of these archived data comparing the extent of weight loss among two groups of
obese and morbidly obese patients. The first group (intervention) completed a behavioral
contract to participate in a 26-week weight loss intervention and also received funding to
offset most program costs. A second group (comparison) was made up of obese and
morbidly obese Beaver Medical Group patients who were offered the regular LiteWeighs program but without the contract element or financial support.
Patients were recruited from September 2009 to February 2010 and offered the
26-week Lite-Weighs program with funding for most costs, excluding meal replacements,
physician visit co-pays, and material fees of $25 per 8-week program cycle for a total of
$75 for 26 weeks. All patients who were referred to the weight loss clinic and met the
inclusion criteria were offered this program. If they accepted they were required to sign a
contract promising participation in 26 weekly treatment sessions. A total of 127 patients
agreed to participate. The comparison group (AM 54) consisted of patients who were
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referred to the weight loss clinic from April 2008 to September 2010 and fit the inclusion
criteria. This group was offered the same program as the intervention group without
funding support and without the 26-week contract requirement. This group chose the
frequency and type of intervention sessions based on their personal preference and ability
to pay and attend the treatment sessions. All participating patients gave consent. Toma
Linda University, Beaver Medical Group, and the Lite-Weighs program entered into a
data use agreement prior the accessing the patient database
B. Description of Study Participants
The study population consisted of obese and morbidly obese men and women
with BMI >30kg/m2. The age range of patients enrolled in the 26-week Lite-Weighs
medically supervised weight loss program at chart abstraction time was 21-75 years.
As part of their standard practice Beaver Medical Group excluded persons with
medical contraindications for calorie restricted and fat reduced diets, moderate exercise,
and those with active cancer and pregnancy. A medical clearance for participation was
obtained prior to enrollment in the Lite-Weighs program. Consent to enroll in the
program was obtained by the Beaver Medical Group. In addition, study approval was also
obtained from the Loma Linda University Institutional Review Board (Appendix F).
C. Participant Recruitment
All participants were self-referred or physician-referred to the Lite-Weighs
medically supervised weight loss program. Most referrals were from a local HMO
(Beaver Medical Group Primary Care Service). The program was also offered to patients
who had prior knowledge of the services provided by Lite-Weighs, either by previous
attempts to enroll or those who had heard of the program but did not have financial
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resources to enroll. Finally, patients who initially wanted to have bariatric surgery (Roux
e Y or gastric banding), but were no longer interested in the surgical option were also
invited.
D. Intervention Procedures
Potential participants attended a group orientation session which provided an
overview of the program. The goal of the Lite-Weighs treatment program was to support
patients in learning and practicing the lifestyle skills and health habits needed to lose
weight, maintain weight loss, and improve overall health. The Lite-Weighs program
consisted of interdisciplinary staff with specialized training in behavior modification.
weight management, and exercise physiology. The team included physicians, preventive
care specialists, health educators, medical assistants, and a personal trainer. Personalized
attention and follow up care were central to this medically directed program.
Individual programs were designed in collaboration with the patient, supervising
physician and a preventive care specialist during the initial consultation period. At
subsequent weekly meetings, patients met with the intervention team as indicated.
Patients also visited a physician every 3-4 weeks or more often if medically indicated.
The comparison group was offered a similar intervention program as the
intervention group. However, no contract was signed, and this group paid for all of the
sessions that they attended.
1. Dietary Intervention
Intensive or moderate individual nutrition plans were designed to meet
participants’ needs. Patients who needed to lose 50 or more pounds were offered a very
low calorie diet (VLCD), low calorie diet (LCD) or customized plan (calorie requirement
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determined based on age, gender, height, and activity levels) in consultation with Lite
Weighs team. Patients continued on this diet until one-half to three-quarters of the desired
weight loss was achieved; after that a moderate eating plan allowing 1,000-1,200 calories
per day was instituted to lose the remaining pounds. Moderate eating plans were
recommended for desired weight loss of less than 50 pounds. In addition to
individualized diets the program also provided options for nutritional shakes, bars,
packaged meals, and other supplements. All purchases of such foods were noted in the
patient’s file and were abstracted as part of the creation of the data set.
2. Physical A ctivity
Participants were asked to engage in regular exercise for a minimum of 60
minutes per day most of days, and asked to keep records of their activity. An exercise log
was provided to each patient and reviewed during sessions.
3. Behavioral Therapy
Behavior therapy included instructing patients to set goals, self-monitor,
employ stimulus control, solve problems, engage in cognitive restructuring, implement
stress management skills learned through the program and use positive reinforcement to
enhance adherence to prescribed physical activity, diet and other elements of weight loss
program.
4. Adjunctive Weight Loss Medication
Each participant received individual consultation with the supervising
physician to determine if adjunctive weight loss medication should be included. The
weight loss medication Phentermine was made available for patients to use while in the
Lite-Weighs program. Type and duration of medication use was recorded.
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5. Intervention Classes
The intervention program provided weekly one hour sessions for 26
weeks. These sessions were divided into blocks of 8 weekly classes. For example, the
General Pathway class focused on lifestyle transformation skills, details of dietary,
exercise and behavioral elements, and methods of accounting for dietary and exercise
behaviors. The Nutritional Pathway class focused on nutritional skills building,
understanding carbohydrates, fibers, fat and proteins, food demonstrations, meal planning
and calorie requirements. The Wellness Pathway class taught effective methods of
behavior change, combined exercise and nutrition, journal keeping, and increasing
fitness. Emotional Brain Training focused on changing the neuronal network which
favors maladaptive behaviors such as cravings, emotional overeating, and mastering the
skills needed to turn off those drives, to identify and to modify patterns which contribute
to unhealthy choices. The outcomes of the initial assessment guided the type and
sequence of classes suggested. Classes were offered during day and evening hours to
accommodate patient schedules.
6. Measurements
a. Anthropometry Height was measured using a wall mounted
stadiometer to the last completed 0.1 cm after keeping heels, buttocks, shoulders, and
occiput in the vertical plane and head in the anatomic plane. Weight was measured using
a digital weighing scale (Perspective Enterprise, Inc.) with minimal lightweight clothing
to the closest 100 g. BMI was calculated as weight (kg)/height (nf). Waist circumference
was measured with a tape placed around the bare abdomen just above the patient’s
hipbone. The patient was instructed to relax and exhale prior to the measurement. Hip

49

circumference was measured same as the waist except for tape position. The tape was
placed at the maximal circumference over the buttocks.
b. Questionnaires Participants in the intervention group also completed
five psychosocial and behavioral questionnaires prior to the start of the treatment
protocol. This was conducted in a quiet study room with an interventionist available to
answer any questions.
c.

Major Life Change Events The Life Event Scale (Appendix C) is

designed to predict the likelihood of disease (obesity) and illness and the needed
readjustment (weight loss) to return to homeostasis following exposure to stressful life
events. Each life event was given a score that indicated the amount of readjustment a
person had to make as a result of the event. Not all of the events in the scale were
necessarily negative or positive.
Patients were asked to note events that occurred in the past such as death of a
family member, job loss, divorce, etc., and whether these events were related to their
current health condition. They were also asked to record a score for each of these events.
In case an event occurred more than once the patient was instructed to multiply the score
by the number of occurrences. A total score of 300 or more indicates that the patient is at
major risk of illness; a score of 150-299 indicates moderate risk for illness (reduced by
30% from the previous risk), and a score of 150 and below has only a slight risk for
illness. The higher the score (risk) the higher the burden and the more effort needed by
the obese person to return to desirable weight state.
d. The Hassles and Uplifts Scale The Hassles and Uplifts Scale is an
alternative method to the traditional life events approach to measuring stressors, and
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assesses respondents’ attitudes about daily situations. Instead of focusing on highly
charged life events, the 53-item scale provides a comfortable way to evaluate positive and
negative events that occur in each person's daily life, empowering clients to develop
strategies for dealing with hassles and enhancing the occurrence of uplifts. The Uplifts
scale suggests how positive aspects of daily life counteract the damaging effects of stress.
It is graded 0 to 3 for none or not applicable, 1 for somewhat, 2 for quite a bit, and 3 for a
great deal, respectively. It takes approximately 10 minutes to complete the scale
(Appendix D).
e.

Weight Management Behavior Questionnaires In addition to the

questionnaires used to assess the impact of daily and major life events, two weight loss
behavior questionnaires were used in this study. Patients were asked to quantify their
perceived importance and actual frequency of engaging in 17 different weight loss
promoting behaviors (Appendix A and B). The questions focused on three main
categories of behaviors: self-monitoring, eating, and exercise. Self-monitoring questions
captured data regarding use of food diaries, i.e., tracking calories, measuring food
portions, logging exercise and weight values. Dietary habit questions include strictly
following menu plans, smaller food portions, meal planning, restaurant eating, and
thoughts about healthy eating. Physical activity questions covered whether participants
exercised at least 60 minutes per day, participated in supervised sessions on changing the
thoughts related to exercise, and exercised even when not in the mood.
E. Data Collection
Archived data from patient records was reviewed and analyzed. For the baseline
characteristics, patient medical history questionnaire entries were reviewed and
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demographics (age, race, marital status, employment, and education) and anthropometric
data (height, weight, waist circumference and others) extracted. The presence of obesityrelated medical illness (cardiovascular disease, type 2 diabetes, osteoarthritis, and
endocrine disorders), and medication use were determined. Family history of obesity.
cigarette smoking, physical activity and alcohol use were also recorded. Prior attempted
dieting methods were recorded.
For the current program all treatment modalities were recorded including dietary
prescription, use of weight loss medication, number of treatment sessions attended and
use of diet supplements. At the end of treatment (26 weeks), or whenever the participant
dropped out of the study, weight and waist and hip measurements were recorded.
The patients completed questionnaires were added to the data set and scored
according to published guidelines. Data was also reviewed for 10 most frequently
reported major life events, uplifts and hassles were identified.
Persons with medical contraindications for calorie restricted and fat reduced diets,
moderate exercise, and those with active cancer and pregnancy were excluded.
F. Data Analysis
Abstracted data was entered using SAS version 9.2 software for Windows. A
random 10% sample was re-entered. The dependent variables (changes in weight change,
BMI, and waist circumference) were examined for normality; distributions were normal
therefore did not require transformations. Descriptive analysis was completed for
participants’ baseline variables and expressed as mean +/- standard deviations. An
independent sample t-test was used to compare continuous variables in the intervention
versus the comparison group. Chi square analysis was used for categorical variables.
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Changes in weight, BMI, and waist circumference were calculated and compared
between the intervention and comparison groups using the independent t-test (for some of
the variables that appear in the descriptive statistics, the distribution was non-normal; for
these variables, the Mann-Whitney test was used. Paired t-tests were used to examine
changes in weight, BMI and waist circumference. Multiple linear regression was used to
determine if changes in BMI or weight were associated with the psychosocial and
behavioral questionnaire scale results; these variables were added to the model. The
intent-to-treat approach was used to analyze data, with the last observation carried
forward.
Multiple linear regressions were used to evaluate predictors of weight loss,
adjusting for covariates. The dependent variables were changes in weight and BMI.
Models were adjusted to the baseline value of the corresponding measure. Covariates
were checked, and any variables that were significant or that changed the beta coefficient
of the treatment variable by 10% were included in the model. Model selection was
performed for each of the dependent variables. In addition variables that differed between
groups at baseline and after the weight loss intervention were included in the models. The
alpha (p-value) < .05 was used as criteria for statistical significance.
Psychosocial correlate analyses: Multiple linear regression was used to determine
if changes in BMI or weight were associated with psychosocial and behavioral
questionnaire scale results. Significant variables were added to a final analytic model.
G. Power Analysis
The research questions concerning the intervention and comparison groups used
multiple regression modeling to determine weight change on multiple (7 to 9) covariates.
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With a sample size of 240 observations (participants?) provided 82% power and a 0.05
(two-sided) significance level. We also determined that we had sufficient power with the
100 persons who completed the psychosocial questionnaire, noting that with a multiple
regression we could model weight change on continuous independent variables (Xs) and
achieve 85% power at a 0.05 significance level (two-sided) to detect a change in Rsquared of 0.08.
H. Ethical considerations
The Beaver Medical Group obtained participant consent at the beginning of
patient enrollment. Participants were asked to provide consent for the investigator to
access their patient data, including weight loss and health history, and evaluations
performed by the physician, preventive care specialists, health educators, and for
participation in the behavioral interventions. Participants in the intervention group also
signed an agreement to attend 26 weekly sessions. They were asked to complete the
psychosocial questionnaires, and to allow Lite-Weighs staff to collect anthropometric
measurements. To reduce the undue burden that may be caused by the frequency of the
visits, appropriate times and dates were chosen in consultation with the patient. Data
were secured and kept in a locked file cabinet at Beaver Medical Group. Participant data
was de-identified using ID numbers and the data set with the linking code was shredded
at the completion of the study. Only de-identified data were used in the analyses.
While there may have been an initial risk such as divulging personal information
with the intervention team and other participants during group discussions this was
limited to the provider setting and since only de-identified data was used, did not affect
the conduct of this study. Stringent medical provider standards regarding patient
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confidentiality were followed throughout the study. Patients were informed that changes
in diet and increased physical activity may alter baseline physiology such as resulting in
hypo or hyperglycemia, joint pain, and others. The physician and the rest of the
intervention team were available to adjust patients’ dietary intake, exercise regimen or
medication in consultation with their primary care physician. During weekly meetings
progress notes were taken to evaluate patients’ tolerance and adjustment to the behavior
change approaches.
Patients were told that benefits could include acquiring skills necessary to lose
weight through dietary modification, physical activity, and behavior change. They also
could benefit from making connections with peers and developing confidence. The
weekly obesity-related health assessments by a trained multi-disciplinary intervention
team could identify other obesity related issues and help develop an appropriate plan for
care. Patients in the intervention group also benefited from financial assistance to offset
program costs associated with participation in an intensive weight management program.
I. Limitations
All study participants were self selected. Participants were free living and there
was no control over other sources of information that may have affected the intervention.
The questionnaires depended on the accuracy of self-reports by the patients. Patients may
have overestimated their efforts to please the staff. Participants self-selected into the
study, choosing either the intervention or comparison group, resulting in non-random
group assignment. The questionnaires were somewhat lengthy and available only in
English, although no patients asked for questionnaires translated into Spanish or any
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other language. The study team who handled the secondary data analyses had no physical
interaction with the participants.
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ABSTRACT
Background and Aims: Engaging in a healthy lifestyle that includes diet, physical
activity, and behavioral modification can influence weight loss. In addition, factors that
promote weight loss could also include financial incentives, attendance at intervention
sessions, adjunctive weight loss medication and supplemental diet products. The purpose
of this study was to investigate whether an intensive weight management program was
associated with clinically significant weight loss in obese and morbidly obese patients as
well as predictors of weight loss.
Methods: We compared weight loss among patients who chose to participate in a 26week intervention including an attendance contract and funding to offset most program
costs (intervention group) to patients who were offered the program without the contract
component or financial support (comparison group). Patients were self-referred or
referred by their primary care physician. Archived data from patient medical records was
reviewed and analyzed. Participants were men and women ages 21-75 years with a
BMI >30 kg/nT. The intervention group was offered the grant covering a wide spectrum
of intervention classes and signed an agreement to attend weekly sessions for 26 weeks.
The comparison group was not offered the grant, and chose the frequency and type of
intervention sessions depending on their willingness to pay and attend. Assessments at
baseline and end of follow-up (weeks 0 and 26) include demographics, anthropometric,
lifestyle and co-morbidity measures. The number of therapy sessions attended, adjunctive
medication use, and supplemental diet products purchased were recorded. The main
outcome was percentage change in weight compared to baseline.
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Results: There were 23 men and 104 women in the intervention group (BMI=40.5±8.7)
and 36 men and 118 women (BMT= 39.4±7.1) in the comparison group. Both experienced
significant decreases (7.6±9.7 kg, or 6.7% from baseline for the intervention group vs.
6.2±6.3 kg or 5.8% for the comparison group) in weight using intent-to-treat analysis
with no difference between groups. Those who started with higher weight (p<0.0011),
attended more sessions (p=0.0395) and used adjunctive weight loss medication
(p=0.0084) lost more weight. Depression was associated with lower weight loss.
Conclusion: Both programs induced clinically significant weight loss (>5%) over 26
weeks, with no advantage observed between the intervention and comparison groups.
Predictors of weight loss were in line with previous literature, and we were able to
identify factors that should be addressed in weight intervention programs.
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INTRODUCTION
Obesity is a complex chronic disease that develops over years or decades. There is
an urgent need to identify treatment approaches that may contribute to weight loss
success. Modest weight loss can lead to a significant reduction in co-morbidities
associated with obesity. Risk factors for obesity have been attributed to genetic,
behavioral, environmental, and physiological factors (Flegal, et ah, 2001). Most weight
management programs focus on reducing caloric intake. However, it is clear that energy
restriction alone is not sufficient. Some studies indicate that a clinic-based, healthylifestyle program resulted in significant weight loss (Riebe, et ah, 2003). However a
systemic review of major commercial weight loss programs concluded that the evidence
to support the use of such programs is minimal (Baker & Young, 2006; Tsai & Wadden,
2005).

While few dispute the need for weight loss it is important to identify factors
associated with successful weight loss. These factors could include adjunctive therapies
to dietary change (Astrup, et ah, 2000; Jeffery, et ah, 1993; Rolls, et al., 2002; Yu-Poth,
et al., 1999), including increased physical activity (Ballard & Poehlman, 1994; Jeffery, et
al., 1984; Wadden, et al., 1997; Wing, 1999), social support (Wing, 1999), behavior
therapy (Wadden & Foster, 2000), increased intensity with more frequent intervention
sessions (Butsch, et al., 2007; Jeffery, et al., 1993), financial incentives (Giuffrida &
Torgerson, 1997; Janz, Becker, & Hartman, 1984; Kane, Johnson, Town, & Butler,
2004), contracting (Neal, 1991), use of adjunctive weight loss medication (Stanfford &
Radley, 2003; Wirth & Krause, 2001) and supplemental diet products (Jeffery, et al.,
1993). In its 2007 report, the Institute of Medicine (IOM) identified identifying effective
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obesity management strategies as an essential priority action. It also emphasized that each
evaluation can make an important contribution to the evidence base (IOM, 2007).
Many point to high out of pocket costs as a barrier to treatment (Bryant, 2001;
Federal Trade Commission, 2006) as insurance coverage of obesity treatment is patchy in
the U.S. (Tsai, Ash, & Wadden, 2006). Some studies have shown that financial incentives
improve the effectiveness of obesity treatment programs (Jeffery, et al., 1983, 1984).
Hubbert et al., (2003) showed that among participants in a weight loss program, those
receiving modest financial incentives (50% of the $300 weight loss program fee if
participants attended 10-12 sessions and lost 6% of their initial body weight) had
significantly higher chances of attending the recommended number of sessions and
achieving successful weight loss. However, in meta-analysis the use of financial
incentives did not promote successful weight loss or maintenance (Paul-Ebhohimhen &
Avenell, 2008).
Failure to attend the required intervention sessions may be associated with failure
to complete the treatment regimen or follow prescribed lifestyle changes and as a result a
failure to achieve weight loss benchmarks. A systemic review of medically supervised
proprietary weight loss programs has shown a 19%-56% attrition rate during 26 weeks of
treatment (Tsai & Wadden, 2005).
The World Health Organization reports that for diseases associated with lifestyle
poor adherence to treatment is associated with worse health outcomes (WHO, 2003).
Effective strategies need to be developed to improve patient adherence (Haynes, 2008). A
written or verbal contract asking the patient to commit to adhere to the prescribed set of
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treatment components may improve patient adherence (Bosch-Capblanch, et ah, 2009;
Neale, 1991).
According to the National Heart, Lung, Blood Institute (NHLBI), successful long
term weight loss is defined as an intentional reduction of 5-10% from baseline
maintained for one year. Such weight loss, though modest, improves a host of
cardiovascular risk factors (Blackburn, 1995; Goldstein, 1991; Oster, et al., 1999),
prevents the development of type 2 diabetes, and is achievable in clinical practice. The
1998 National Institutes of Health (NIH) clinical guidelines indicate that decreased
caloric intake, moderate physical activity, and behavioral therapy constitute vital
elements of any effective weight loss and maintenance program. Furthermore,
multidisciplinary programs that focus on positive lifestyle change and include expertise
in health education, nutrition, exercise and behavior change are recommended.
Lite-Weighs is a medically supervised, multidisciplinary weight loss program
located in Redlands, California. The program serves overweight, obese, and morbidly
obese patients who are self referred or physician-referred. The program focuses on health
education, lifestyle skills development, behavior modification, nutrition, and physical
activity. Lite-Weighs also provides options for diet supplements and medications to
enhance weight loss.
In the current study we investigated if offering financial support for program
expenses and obtaining a signed contract committing the individual to attend a prescribed
number of intervention sessions resulted in greater weight loss than the standard care
provided by the Lite-Weighs program. We also sought to determine significant predictors
of weight loss.
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METHODS
A. Subjects
The study population consisted of obese and morbidly obese men and women
aged 21-75 years with BMI >30 kg/m“. All participants were self or physician-referred to
the 26-week Lite-Weighs medically supervised weight loss program. Most referrals were
from a local health maintenance organization Beaver Medical Group from September
2009 to February 2010 the Beaver Medical Group offered financial support covering
most program expenses, with the exception of the cost of meal replacements, physician
co-pays, and a $25 material fee per each 8 week class for a total of $75 during the 26
week program. All referrals in this time period were offered this program and were
required to sign a contract promising participation in weekly treatment sessions.
Participants in this program are referred to as the intervention group. The comparison
group consisted of patients who enrolled from April 2008 to September 2010 and were
offered the identical treatment program to the intervention group without financial
support and or the contract requirement. This group chose the frequency and type of
intervention sessions depending on their willingness to pay for and attend the treatment
sessions. Referred patients who had shown interest in bariatric surgery but decided
against it were invited to participate in either program. Consent to enroll in the program
was provided by Beaver Medical Group.
B. Treatment
Potential participants attended a group orientation session which provided an
overview of the program. The goal of the Lite-Weighs treatment program was to support
patients in learning and practicing the lifestyle skills and health habits needed to lose
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weight, maintain weight loss, and improve overall health. The Lite-Weighs program
consisted of an interdisciplinary program with staff with specialized training in behavior
modification, weight management, and exercise physiology. The team included
physicians, preventive care specialists, health educators, medical assistants, and a
personal trainer. Personalized attention and follow up care were central to this medically
directed program.
Individual programs were designed in collaboration with the patient, supervising
physician and preventive care specialist during the initial consultation period. At
subsequent weekly meetings, patients met with the intervention team as indicated.
Patients also visited either the Lite-Weighs physician or their own personal physician
every 3-4 weeks or sooner if medically indicated.
The comparison group was offered the same program as the intervention group,
however, no contract was signed, and this group paid for all of the sessions they attended.
1. Dietary Intervention
Intensive or moderate individual nutrition plans were designed to meet
participants’ needs. Patients who needed to lose 50 or more pounds were offered a very
low calorie diet (VLCD), low calorie diet (LCD) or customized plan (calorie requirement
determined based on age, gender, height, and activity levels) in consultation with the Lite
Weighs team. Moderate eating plans were recommended for desired weight loss of less
than 50 pounds. In addition to individualized diets, the program also provided options for
nutritional shakes, bars, packaged meals, and other supplements.
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2. Physical Activity
Participants were asked to engage in regular exercise for a minimum of 60
minutes per day most of days, and asked to keep records of their activity. An exercise log
was provided to each patient and reviewed during sessions.
3. Behavioral Therapy
Behavior therapy included instructing patients to set goals, self-monitor,
employ stimulus control, solve problems, engage in cognitive restructuring, implement
stress management skills learned through the program and use positive reinforcement to
enhance adherence to prescribed physical activity, diet and other elements of weight loss
program.
4. Adjunctive Weight Loss Medication
Each participant received individual consultation with the supervising
physician to determine if adjunctive weight loss medication should be included. The
weight loss medication Phentermine was made available for patients to use while in the
Lite-Weighs program. Type and duration of medication use was recorded.
5. Intervention Classes
The intervention program provided weekly one hour sessions for 26
weeks. These sessions were divided into blocks of 8 weekly classes. For example, the
General Pathway class focused on lifestyle transformation skills, details of dietary,
exercise and behavioral elements, and methods of accounting for dietary and exercise
behaviors. The Nutritional Pathway class focused on nutritional skills building,
understanding carbohydrates, fibers, fat and proteins, food demonstrations, meal planning
and calorie requirements. The Wellness Pathway class taught effective methods of
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behavior change, combined exercise and nutrition, journal keeping, and increasing
fitness. Emotional Brain Training focused on changing the neuronal network which
favors maladaptive behaviors such as cravings, emotional overeating, and mastering the
skills needed to turn off those drives, to identify and to modify patterns which contribute
to unhealthy choices. The outcomes of the initial assessment guided the type and
sequence of classes suggested. Classes were offered during day and evening hours to
accommodate patient schedules.
C. Data Collection
Archived data from patient records was reviewed and analyzed. For the baseline
characteristics, patient medical history questionnaire entries were reviewed and
demographics (age, race, marital status, employment, and education) and anthropometric
data (height, weight, waist circumference and others) extracted. The presence of obesityrelated medical illness (cardiovascular disease, type 2 diabetes, osteoarthritis, and
endocrine disorders), and medication use were determined. Family history of obesity,
cigarette smoking, physical activity and alcohol use were also recorded. Prior attempted
dieting methods were recorded.
For the current program all treatment modalities were recorded including dietary
prescription, use of weight loss medication, number of treatment sessions attended and
use of diet supplements. At the end of treatment (26 weeks), or whenever the participant
dropped out of the study, weight and waist and hip measurements were recorded.
The patients completed questionnaires were added to the data set and scored
according to published guidelines. Data was also reviewed for 10 most frequently
reported major life events, uplifts and hassles were identified.
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Persons with medical contraindications for calorie restricted and fat reduced diets,
moderate exercise, and those with active cancer and pregnancy were excluded.
D. Measurements
Height was measured using a wall mounted stadiometer to the last completed 0.1
cm after keeping heels, buttocks, shoulders, and occiput in the vertical plane and head in
the anatomic plane. Weight was measured using a digital weighing scale (Perspective
Enterprise, Inc.) with minimal lightweight clothing to the closest 100 g. BMI was
calculated as weight (kg)/height (m2). Waist circumference was measured with a tape
placed around the bare abdomen just above the patient’s hipbone. The patient was
instructed to relax and exhale prior to the measurement. Hip circumference was measured
same as the waist except for tape position. The tape was placed at the maximal
circumference over the buttocks.
E. Data Analysis
Abstracted data was entered using SAS version 9.2 software for Windows. A
random 10% sample was re-entered. The dependent variables (changes in weight change,
BMI, and waist circumference) were examined for normality; distributions were normal
therefore did not require transformations. Descriptive analysis was completed for
participants’ baseline variables and expressed as mean +/- standard deviations. An
independent sample t-test was used to compare continuous variables in the intervention
versus the comparison group. Chi square analysis was used for categorical variables.
Changes in weight, BMI, and waist circumference were calculated and compared
between the intervention and comparison groups using the independent t-test (for some of
the variables that appear in the descriptive statistics, the distribution was non-normal; for
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these variables, the Mann-Whitney test was used. Paired t-tests were used to examine
changes in weight, BMI and waist circumference. Multiple linear regression was used to
determine if changes in BMI or weight were associated with the psychosocial and
behavioral questionnaire scale results; these variables were added to the model. The
intent-to-treat approach was used to analyze data, with the last observation carried
forward.
Multiple linear regressions were used to evaluate predictors of weight loss.
adjusting for covariates. The dependent variables were changes in weight and BMI.
Models were adjusted to the baseline value of the corresponding measure. Covariates
were checked, and any variables that were significant or that changed the beta coefficient
of the treatment variable by 10% were included in the model. Model selection was
performed for each of the dependent variables. In addition variables that differed between
groups at baseline and after the weight loss intervention were included in the models. The
alpha (p-value) < .05 was used as criteria for statistical significance.
F. Results
Baseline characteristics and measures were similar between participants in the
intervention versus comparison groups as shown in Table 1. The dropout rate in the
intervention group was 16 persons (12.6%) versus 25 persons (16.2%) for the comparison
group.
There were no significant differences in weight, BMI, or waist circumference at
baseline between the two groups. There was no significant difference between groups in
the number of obesity related diseases (Table 1) except for cardiovascular disease.
Slightly more intervention group participants had cardiovascular disease than comparison
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participants. Lifestyle data (Table 1) revealed no significant differences in the level of
physical activity and alcohol consumption between the two groups at the start of the
program. However, more subjects in the comparison group had never smoked cigarettes
compared to the intervention group. Similarly, more patients in the comparison group
were employed than intervention group participants.
During the treatment period, there was a significant difference between the two
groups in the number of sessions attended and use of adjunctive weight loss medication,
with more participants in the comparison group using weight loss medications. The
intervention group attended 12.7 more weekly sessions compared to the comparisons.
Intervention group participants used more diet supplements than the comparison group
(see Table 2).
There was clinically significant percent reduction in weight or BMI in both
groups at 26 weeks. Figure 1 shows a scatter plot of the percent change in weight vs.
baseline weight by group. As shown in Table 3, intent-to-treat analysis, those in the
intervention group lost 6.68% weight/BMI change vs. 5.84% weight/BMI for the
comparison group. However, the treatment effect was not significant in any of measures
(percent weight /BMI change) adjusting for covariates (Table 3).
Table 4 shows multiple regression analysis for percent weight change at 26
weeks. Covariates were checked, and any variables that were significant or that changed
the beta coefficient of the treatment variable by 10% were included in the model. In
addition, monitored variables and baseline patient characteristics that had significant
group differences were included in the model.
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Baseline weight was predictive of weight loss success. The number of sessions
attended was significantly associated with change in weight and change in BMI between
baseline and 26 weeks. In addition, adjunctive medication usage was significantly
associated with percent weight change, and percent BMI change. Those who attended
more sessions or those who used weight medication achieved greater weight loss.
Baseline weight and BMI were associated with greater weight loss; those with higher
weight/BMI showed greater decrease in percent weight or BMI. There were no effects of
quantity of supplement use. In terms of achieving medically significant weight loss 86
persons (55.8%) in the comparison group and 69 (54.33%) in the intervention group lost
>5%, (p=0.7996), of baseline weight at 26 weeks (see Table 4).
G. Discussion
Findings from this study show no significant difference in percent weight loss
between the intervention and comparison groups. The program that offered a financial
incentive and required an attendance contract did not promote greater weight loss than
the comparison program, but several predictors of success were identified. We found that
both weight management programs successfully promoted significant weight loss (>5%)
over a period of 26 weeks. Comparison group participants lost about 6% of their total
weight and the intervention group lost about 7%, however, the difference was not
statistically significant. It appears that the groups used different strategies to achieve
weight loss; the comparison group participants were more likely to use adjunctive weight
loss medications, while the intervention group attended more sessions and relied more on
program components.
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Although the financial support and contractual agreement had no significant effect
on weight loss (5.84% in the comparison group vs. 6.68% in the intervention group).
there was a strong association between number of sessions attended, use of weight loss
medication, initial BMI/weight and percent weight loss. Depression was associated with
less success with weight loss.
Previous studies suggest that providing economic incentives improves weightg
loss program outcomes (Jeffery, et al., 1983; Jeffery, et ah, 1984). Volpp, et al., (2008)
reported that the use of financial incentives produced significant loss during 16 weeks of
intervention. However, our findings are consistent with a meta-analysis of financial
incentives on weight loss, which found no significant effect (Paul-Ebhohimhen &
Avenell, 2008).
Similarly, a systemic review by Cochrane Database (2008) concluded that there is
not enough reliable evidence to recommend the routine use of contracts to improve
adherence in health care or other programs.
Weight management interventions that involved signing a contract (Aragona,
1975) reported that subjects in the contract group lost more weight than the control
group. Craighead (1989) reported that subjects in the contract and supervised group lost
more weight than those in the minimal care group. However, Murphy (1982) found no
statistically significant differences in mean weight loss, percentage of excess weight loss
and weight reduction index. Our study suggests that although there was no significant
difference in percent weight loss between treatment groups which used signed contracts
and those which did not, it was associated with higher session attendance.
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A previous study by Tsai and Wadden (2005) concluded that weight loss
programs should be evaluated for efficacy since many people seek out these programs
without sufficient scientific evidence of program success. The study results suggested
that the effectiveness of commercial weight loss programs was inconclusive. However,
our study findings showed that participants in either the intervention or comparison group
could expect to lose >5% of their initial weight, which is clinically significant weight
loss.
Multidisciplinary obesity intervention programs that incorporate nutritional
guidance (Astrup, et ah, 2000; Brehm, et ah, 2003; Samaha, et ah, 2003;Yu-Poth, et ah,
1999), physical activity (Bouchard, et ah, 1990; Wing, 1999) and behavior therapy
(Klem, et ah, 1997; McGuire, et ah, 1998; Wyatt, et ah, 2002) reported successful levels
of weight loss. The rate of weight loss in our study is less than the outcomes of
OPTIFAST and Health Management Resources programs, which indicated that intensive
multidisciplinary programs induced 15%-25% of the initial weight loss in persons who
completed a 3 to 6 month intervention (Anderson et ah, 1991, 1994; Wadden, et ah,
1992; Walsh & Flynn, 1995). The Diabetes Prevention Program (DPP) trial showed that
intensive supervised programs resulted in >7% body weight loss in 24 weeks (Diabetes
Prevention Research Group, 2002). The results from our intervention group were similar
to those found in the DPP study.
Results from our study show that a medically supervised weight loss program that
offered financial support and required an attendance contract successfully facilitated a
weight loss of about 7% of initial body weight and on average about a 17 lbs. weight loss.
It also showed that a self-paced program without an attendance contract or financial
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support resulted in clinically significant loss of about 6% (13.9 lbs) of initial weight in 6
months. Evidence from controlled randomized studies shows that weight loss of as little
as >5% of initial body weight is considered clinically significant because it can improve
associated comorbidities (Pi-Sunyer, 1996; Goldstein, 1992; American Diabetes
Association [ADA]and National Institute of Diabetes, Digestive, and Kidney Disease
[NIDDK], 2002). It takes about 6 months for most patients to achieve a new equilibrium
of energy balance (National Institutes of Health [NIH], NHLBI, and the North American
Association for the Study of Obesity [NAASO], 2000).
Attendance at intervention sessions and program adherence were related to weight
loss success. This is consistent with findings of Jeffery et al. (1993) and Butsch et al.
(2007) which indicated that attending more treatment sessions was associated with
highest odds of meeting weight loss benchmarks. Wadden et al. (1992) and Perri et al.
(1993) also reported similar findings. Our findings also are consistent with a study by
Finley et al. (2006), which reported that commercial weight loss programs can be
effective for individuals who attend more sessions. With 14-26 weeks of participation,
Finley et al. reported about 7.3% (±4.5) weight loss. Participants with frequent contact
with interventionists as indicated by number of sessions attended may have better support
and compliance that translated into higher weight loss outcomes.
Targe numbers of studies have addressed the association between baseline
weight/BMI and change in weight/BMI after treatment (Foster, et al., 1998; Galdis, et al.,
1998; IOM, 1995; Feibbrand & Fichter, 2002; Traverse, et al., 2000; Wing & Jeffery,
1999). Most studies reported a positive association between higher initial weight/BMI
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and greater weight loss after treatment (Teixeira, et ah, 2005). Our study supports these
findings.
Use of Phentermine, an adjunctive weight loss medication, was strongly
associated with weight loss success in both our intervention and comparison groups. In a
randomized clinical trial, Munro, et ah, (1968) attributed to phentermine therapy a weight
loss of about 13% of initial weight compared with 5% for placebo. Weintraup, et ah,
(1992) in a controlled study reported weight loss success when using a combination of
the drugs phentermine and fenfluramine, popularly known as “phen-fen,” when added to
a program of diet, exercise and behavior modification. However, this combination of
drugs later was associated with valvular heart disease (Connolly, Crary, McGoon, et ah,
1997). The drug was removed from the market in 1997. Padwal, et ah, (2009) reviewed
pharmacotherapy for obese and overweight individuals and reported patients using drug
therapy were significantly more likely to achieve >5% weight loss. Studies of the drug
Sibutramine have also showed similar efficacy, producing significant weight loss (Bray,
2001). Our findings also show that those taking weight loss medications achieved a
higher percent weight loss compared with those who did not. The NIH recommends that
drugs should be used in combination with diet, physical activity, and behavior therapy.
In our study, more comparison group participants used weight loss medication
(50%) than the intervention group 37%. Thus, a higher percentage of weight loss in
comparison group may be attributable to medication use.
Some studies have reported a link between supplement use and weight loss (Metz,
Stem, Kris-Etherton, et ah, 2000; Wing & Jeffery, 2001). Jeffery et al. (1993) reported
participants who used prepackaged meals with other components of weight loss
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intervention lost more weight than those who used only a prescribed diet. In this study,
there was no significant difference in weight loss between those who used a prescribed
diet only vs. prescribed diet plus other supplements such as shakes, packaged meals,
nutrition bars and others. These may be attributed to infrequent and minimal supplement
use.
The NIH considers weight loss of >5% of baseline weight in 6 months to be good
outcome for an obese person. By this standard, most participants in both programs
achieved progress towards weight loss. Our current study showed that 55.8% of the
comparison and 58% of the intervention group achieved >5% weight loss, which is
defined as clinically significant. Studies show that fewer than half of obese and morbidly
obese persons attempting to loss significant weight achieve their goal. The current study
suggests that weight loss programs such as Lite-weighs can be effective for individuals
who attended prescribed intervention sessions and used adjunctive weight loss
medication. Depression was found to be obstacle to weight loss success.
H. Study Limitations
Participants self-selected to both study groups, therefore they could have had
similar initial characteristics such as race, gender, dietary habits, and physical activity.
This would decrease the heterogeneity of the sample size. The results may not be
generalizable due to self-selection and lack of randomization.
The sample size was small and the study was powered to detect differences in
weight change between groups rather than differences in physiological markers of weight
change. The purpose of the study, which focused on the program as a whole and not the
individual components, was to investigate whether an intensive weight management
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program enhanced with a contract and financial support for most expenses was associated
with clinically significant weight loss in obese and morbidly obese patients. The choice
of the comparison group also affects the interpretation of the result. The two study groups
may have not been sufficiently different. Controlled trials are needed to assess the
efficacy of these weight loss intervention approaches.
In summary, the outcome of this study suggests that a multidisciplinary,
medically supervised weight loss program was associated with clinically significant
weight loss over a period of six months. The program that was enhanced with a financial
incentive and required an attendance contract did not produce greater weight loss than a
usual care comparison program. The study also demonstrated adjunctive use of weight
loss medication, higher session attendance, and higher initial weight predicted weight
loss success. On the other hand, depression was associated with a lack of weight loss
success.
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Table 4.1 Characteristics of Participants at Baseline Showing number (percentage)
or mean ± standard deviation
Variables
Female, N (%)
White, N (%)
Age (years), mean (SD)
Married, N (%)
Weight, (kg)
BMI ( kg/m2), mean (SD)
Waist, mean (SD)
Hip, mean (SD)
Waist/Hip ratio, mean (SD)
Education, N (%)
High School or less
Associate Degree
Bachelor's Degree or more
Employment, N (%)
Employed
Unemployed/Disabled/Retired
Past weight loss attempts*, N (%)
No, new participants
Yes, attended previously, N (%)
Physical Activity, N (%)
None
Mild
Moderate/Vigorous
Never smoked, N (%)
No alcohol, N (%)

Comparison
(n = 154)
118
(76.6)
(62.3)
96
47.0
(±14.2)
(64.9)
100
(22.7)
105.9
39.4
(±7.1)
111.2
(±15.5)
124.3
(±14.9)
0.90
(±0.09)

Intervention
(n = 127)
104
(81.9)
93
(73.2)
49.8
(±15.6)
(62.2)
79
112.0
(27.5)
(±8.7)
40.5
(±20.2)
115.5
129.8
(±18.0)
0.89
(±0.09)

P-value
0.2807
0.0528
0.1212
0.6357
0.1272
0.3906
0.1815
0.0108
0.3194

80
27
46

(52.3)
(17.7)
(30.1)

55
25
45

(44.0)
(20.0)
(36.0)

0.3835

125
26

(82.8)
(17.3)

68
58

(54.0)
(46.0)

<.0001

104
50

(67.5)
(32.5)

75
52

(59.1)
(40.9)

0.1413

45
49
59
121
109

(29.4)
(32.0)
(38.6)
(79.1)
(71.7)

25
55
47
81
83

(19.7)
(43.3)
(37.0)
(63.8)
(65.4)

0.0801

0.0045
0.2537

31

(20.3)

26

(20.5)

0.9652

21
(13.7)
Thyroid
Cardiovascular
15
(9.8)
High cholesterol
59
(38.3)
Hypertension
76
(49.4)
Depression
57
(37.0)
* Medically supervised commercial weight loss program

21
27
51
58
51

(16.5)
(21.3)
(39.3)
(45.7)
(40.2)

0.5121
0.0075
0.6723
0.5386
0.5897

Co morbidities* N (%)
Diabetes
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Table 4.2 Weight Loss Intervention During Treatment Period
Variables

Comparison
(n = 154)

Intervention
(n = 127)

P-value

Diet Prescription, N (%)
Prescribed diet only
Prescribed diet + additional
supplements
Weight loss medications, N (%).

0.1594

51

(33.1)

32

(25.4)

103

(66.9)

94

(74.6)

77

(50.0)

47

(37.0)

0.0290

19.4

(6.8)

<.0001

47.3

(107.4)

<.0001

(3.3)
6.8
Sessions attended, mean (SD)
Number of Supplements*/whole
12.9
(30.5)
treatment period, mean (SD)
*Recorded in patient file during each purchase made
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Table 4.3 Change in Anthropometric Measures (after - before) using Intent-to-treat
Analysis** (Last Observation Carried Forward-LOCF)
Measures

Comparison
(n = 154)

Intervention
(n = 127)

P-value

Weight change (after - before)

-6.23

(6.3)

-7.58

(9.7)

0.5847

Weight change in percent

-5.84

(5.7)

-6.68

(7.7)

0.7686

BMI change (after - before)

-2.29

(2.3)

-2.74

(3.5)

0.7333

BMI change in percent

-5.84

(5.7)

-6.68

(7.7)

0.7686

Waist change (after - before)

-2.54

(8.7)

-7.19

(9.6)

0.5847

-1.85
(7.6)
Waist change in percent
*Change in Anthropometric measure is a negative number
** Mann-Whitney test

-5.98

(7.6)

0.7686
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Table 4.4 Multiple Regression Analysis of Predictors of change in Weight* (after
before) after 26-weeks
95% Cl
Variables

SE

Beta

lower

upper

P-value

Intercept

-5.552

1.446

-8.400

-2.703

0.0002

Baseline Weight
Treatment group:
Intervention vs. comparison

-0.079

0.019

-0.116

-0.043

<.0001

1.865

1.537

-1.162

4.892

0.2262

Number of sessions attended
Weight Medication use vs. not
Physical Activity:
Mild vs. none
Moderate/vigorous vs. none
Employment:
Retired vs. employed
Unemployed vs. employed
Thyroid vs. none
Depression vs. none
Quantity of supplements
Cardiovascular disease vs. none
Smoke: Ever smoker vs. never
Cl, confidence interval
SE, standard error
*Change in weight is a negative number

-0.257
-2.282

0.091
0.927

-0.436
-4.106

-0.078
-0.457

0.0050
0.0144

0.992
0.242

1.175
1.150

-1.322
-2.022

3.307
2.506

0.3993
0.8337

0.037
0.034
1.831
3.656
0.005
2.169
-0.214

1.406
1.274
1.256
0.927
0.006
1.332
0.653

-2.731
-2.476
-0.641
1.829
-0.007
-0.453
-1.500

2.806
2.544
4.304
5.482
0.017
4.791
1.071

0.9789
0.9789
0.1459
0.0001
0.3787
0.1046
0.7429
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This table will be added as addendum to the dissertation.

Table 4.5 Multiple Regression Analysis of Predictors of Changes in BMI change* (after before)
95% Cl
Variables

Beta

SE

lower

upper

P-value

Intercept

-2.057

0.530

-3.101

-1.013

0.0001

Baseline BMI
Treatment group:
Intervention vs. comparison

-0.069

0.022

-0.111

-0.026

0.0016

0.616

0.560

-0.487

1.720

0.2724

Number of sessions attended

-0.091

0.033

-0.157

-0.026

0.0062

Weight Medication use vs. not

-0.824

0.338

-1.490

-0.158

0.0155

Mild vs. none

0.347

0.433

-0.506

1.200

0.4235

Moderate/vigorous vs. none

0.118

0.424

-0.717

0.953

0.7804

0.031

0.514

-0.982

1.044

0.9514

-0.041

0.466

-0.958

0.877

0.9303

Thyroid vs. none

0.655

0.459

-0.249

1.559

0.1549

Depression vs. none

1.371

0.338

0.705

2.038

<.0001

Quantity of supplements

0.002

0.002

-0.003

0.006

0.4300

Cardiovascular disease vs. none

0.743

0.487

-0.216

1.701

0.1282

Smoke: Ever smoker vs. never
-0.055
Cl, confidence interval
SE, standard error
*Change in BMI is a negative number

0.238

-0.524

0.414

0.8179

Physical Activity:

Employment:
Retired vs. employed
Unemployed vs. employed
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ABSTRACT
Background and Aims: The prevalence of obesity has more than doubled in the last few
decades. Obesity is associated with many health problems. The purpose of this study is to
evaluate psychosocial and behavioral predictors of weight loss success in obese and
morbidly obese men and women enrolled in a medically supervised weight management
program, Lite-Weighs.
Methods and Results: Participants were obese and morbidly obese men and women selfselected to the intervention group, a (n=T27, BMI=40.5 ±8.7) comprehensive clinic based
program which provided financial support to offset most program costs and required an
attendance contract for 26 weekly one-hour sessions. Assessments at baseline and 26
weeks included demographics, anthropometric measures (weight, BMI, waist
circumference) and a behavioral and psychosocial questionnaire aimed at exploring
correlates of weight loss as measured at post test. Of the 127 patients only 100 (79%)
completed the pre-treatment psychosocial and behavioral questionnaire. Participants
experienced significant decreases in weight (-7.58kg) and BMI (-2.74 kg/m2) or 6.8%,
(pO.OOOl) at 26 weeks using intent-to-treat analysis. Multiple linear regression models
identified baseline frequency of engaging in weight loss promoting behaviors (engaging
in exercise, self-monitoring, eating; p=0.045) and depression (p=0.033) as significant and
independent predictors of weight loss. Depression was negatively associated with weight
loss. Major life change events, frequency and intensity of daily stressors, and perceived
importance of weight loss promoting behaviors were not predictive of weight loss
success.
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Conclusions: Pretreatment frequency of engaging at various weight loss enhancing
behaviors were confirmed as predictors of successful weight loss success while baseline
depression was inversely related, suggesting a need for weight loss interventions to
concurrently treat depression.
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INTRODUCTION
In the last few decades the prevalence of obesity among adults in U.S. has sharply
increased (CDC, 2009; Flegal, et ah, 2009). In the absence of genetic change, the increase
in weight is attributed to behavioral and environmental factors such as diet, exercise, and
changes in other lifestyle patterns (Hill, et ah, 1998). Predictors of weight management
have been examined in the past (Brownell, 1984; Foreyt & Goodrick, 1991). These
studies have concluded that predicting weight loss with certainty is difficult and complex.
Potentially many factors are involved contributing only a fraction in the change in weight
making it difficult to build a single predictive model (Foreyt & Goodrick, 1995; Weiss,
1977). Considering the difficulty of predicting outcomes in obesity treatment additional
identification of pre-treatment predictors is essential (Teixeira, et al., 2002).
Studies show that a loss of 5-10% of baseline weight constitutes physiologically
significant weight loss (Blackburn, 1995; Goldstein, 1992; Oster, et al., 1999). A review
of clinic-based, healthy lifestyle interventions found some programs with significant
weight loss (Riebe, et al., 2003). However, systemic reviews of major commercial weight
loss programs (Tsai & Wadden, 2005) concluded that the evidence to support the use of
such programs is minimal and that it is difficult to predict the efficacy of clinically-based
weight-loss programs (Baker & Young, 2006). In 2000, Bish et al. (2005) reported that in
the U.S., 46% of women and 33% of men are trying to lose weight. Despite such efforts a
significant portion of persons appear unable to prevent or reverse obesity. This calls for
developing new solutions to confront this epidemic (Blackburn & Waltman, 2005). Most
weight management programs focus on lowering calorie intake. However, it is clear that
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calorie reduction alone is not sufficient. Efforts also need to target psychosocial and
behavioral factors that may predict failure or success of weight loss.
Successful long-term weight loss is defined as an intentional reduction of 5-10%
from baseline maintained for one year (National Institutes of Health, [NIH] 1998).
Modest weight loss is achievable in clinical settings and improves a host of health risk
factors (Blackburn, 1995; Goldstein, 1992; Oster, et al., 1999), prevents the development
of type 2 diabetes, and is achievable in clinical practice. The NIH clinical guidelines
(1998) indicate that decreased caloric intake, moderate physical activity, and behavioral
therapy constitute vital elements of any effective weight loss and maintenance programs.
In addition, multidisciplinary programs that focus on positive lifestyle change and include
expertise in health education, nutrition, exercise and behavior change are recommended.
Lite-Weighs is a medically supervised, multidisciplinary weight loss program,
operated by the Beaver Medical Group in Redlands, CA. The program serves overweight.
obese, and morbidly obese patients who are self referred or physician-referred. The
program focuses on health education, lifestyle skills development, behavior modification.
nutrition, and physical activity. Lite-Weighs also provides options for diet supplements
and adjunct medications to enhance weight loss.
However, in addition to offering these proven program components it is also
important to explore a variety of psychosocial variables which may influence
participants’ weight loss as potential pretreatment modifiers, thus helping to identify
individuals less likely to succeed at weight loss and match them to the program most
appropriate for them to optimize the success of their treatment.
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For instance, environmental factors (Price & Gottesman, 1991; Stunkard, et al.,
1990) and baseline unhealthy lifestyle behaviors (Flegal, et ah, 2001; Flill, et ah, 1998)
could lead to stressors that greatly impact the homeostasis of the body (Figure 1). When
exposed to stress, the brain’s control center, the hypothalamus and brain-stem, stimulates
neuronal circuits and endocrine pathways, leading to elevation of glucocorticoid levels.
Under chronic exposure this can lead to behavioral and metabolic alterations which can
increase energy intake and decrease energy expenditure, resulting in obesity (Tsigos &
Chrousos, 2002). Major life events and the readjustment required to cope with changes
have been correlated with increased risk of conditions such as obesity (Dohrenwend &
Dohrenwend, 1974). This approach is based on the premise that major life changes lead
to high levels of stress, which combined with inadequate coping skills can lead to chronic
detrimental health outcomes (Holmes & Rahe, 1967).
Thus, a life event scale might be a useful tool to assess the level of stress an
individual is experiencing, possibly leading to overeating, weight gain, and subsequent
health problems. In addition, daily negative events, or hassles, have been found to have
an even greater impact on stress than major life changes (Kanner, et al., 1981).
Individuals exposed to daily hassles such as irritating encounters, frustrations, or work
pressures may experience negative health outcomes as a result of neurohormonal
changes. This in turn increases stress, which may lead to less compliance with a weight
loss regimen and thus, limited success. In contrast, daily positive experiences (uplifts)
such as supportive encounters with friends and family, may help to counter the effects of
hassles, reducing stress and the risk of illness. Individuals with a greater proportion of
uplifts to hassles might be in a better position to achieve successful weight loss.
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To explore this, we used five different psychosocial and behavioral questionnaires
to explore their predictive qualities on success from a medically supervised weight
management program. These include measuring pre-treatment levels of perceived
importance of engaging in weight loss enhancing behaviors (Becker, et ah, 1975), prior
engagement in weight loss enhancing behaviors (Wadden, 1993; Wadden, et ah, 1992;
Wing, 2003), major life events (Holmes & Rahe, 1967), and levels of daily hassles and
uplifts (DeLongis, Folkman, & Lazarus, 1988) which might act as modifiers of weight
loss success.
The purpose of this study was to investigate whether the outcomes of an intensive
intervention program are predicted by pre-treatment identifiable psychosocial and
behavioral variables.
METHODS
A. Subjects
Participants were obese and morbidly obese men and women aged 21-75 years
with BMI >30 kg/m2. Participants were self-referred or physician-referred to the 26-week
Lite-Weighs medically supervised weight loss programs. From September 2009 to
February 2010 financial support covering most program expenses was available. Support
did not cover the cost of meal replacements, physician co-pays, or materials fees ($25 per
8 week class for a total of $75). All referrals in this time period were offered this program
and were required to sign a contract promising participation in weekly treatment sessions,
as well as the completion of a psychosocial and behavioral questionnaire. Consent to
enroll in the study was obtained by the provider and approval for analyses of the de-

96

identified data base was given by Loma Linda University Institutional Review Board
(Appendix F).
B. Treatment
Potential enrollees attended a group orientation session which provided an
overview of the program. Those who chose to participate completed an array of medical
history assessment forms and agreed to commit to the intervention, signed a behavioral
contract to attend 26 weekly one-hour sessions, and completed the pre-treatment
psychosocial and behavioral questionnaire. Program content was designed individually
by the provider and the patient during the initial consultation period. At subsequent
weekly meetings, patients met with the intervention team as indicated. Patients also
visited either the Lite-Weighs physician or their own personal physician every 3-4 weeks
or sooner if medically indicated.
The goal of the Lite-Weighs treatment program was to support patients in learning
and practicing the lifestyle skills and health habits needed to lose weight, maintain weight
loss, and improve overall health. The Lite-Weighs program is implemented by an
interdisciplinary staff with specialized training in behavior modification, weight
management, and exercise physiology. The team includes physicians, preventive care
specialists, health educators, medical assistants, and a personal trainer. Personalized
attention and follow up care are central to this medically directed program.
The medical weight loss treatment program included dietary modification.
physical activity, behavioral therapy, and adjunct weight loss medication. In addition,
intervention classes met weekly for one hour sessions for a total of 26 weeks. These
sessions focused on wholesome lifestyle transformation skills, stressed exercise and
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behavioral elements, and focused on nutritional skills building. The outcomes of the
initial assessment guided the type and sequence of classes suggested. Classes were
offered during day and evening hours to accommodate patient schedules.
C. Data Collection
Upon intake all information was entered into the patient files. Archived data was
reviewed, coded, and analyzed. For the baseline characteristics, patient medical history
questionnaire entries were reviewed and demographics (age, race, marital status.
employment, and education) and anthropometric data (height, weight, waist
circumference and others) were extracted. The presence of obesity-related medical illness
(cardiovascular disease, type 2 diabetes, osteoarthritis, and endocrine disorders), and
medication use were determined. Family history of obesity, cigarette smoking, physical
activity and alcohol use were reviewed and recorded. Prior attempted dieting methods
were recorded.
The pretreatment psychosocial and behavioral questionnaires were reviewed and
scales constructed. Data was also reviewed for 10 most reported frequently experienced
major life events, uplifts and hassles at baseline and at the end of treatment (26 weeks), or
whenever the participant dropped out of the study, data was collected regarding weight.
waist and hip measurements. In order to test if the change in BMI or weight were
associated with psychosocial and behavioral questionnaire scale results, multiple linear
regression was used and these variables were added to the model.
We excluded persons with medical contraindications for calorie restricted and fat
reduced diets, moderate exercise, and those with active cancer and pregnancy. The main
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outcome measure was percent change in weight, but change in BMI and waist
circumferences was also calculated.
D. Measures
Participants completed psychosocial and behavioral questionnaires prior to the
start of the treatment protocol. This was conducted in quiet study room with an
interventionist available to answer any questions.
1. Major Life Change Events Questionnaires
The Life Event Scale (see Appendix C) is designed to predict the
likelihood of disease (obesity) and illness and the needed readjustment (weight loss) to
return to homeostasis following exposure to stressful life events. Each life event was
given a score that indicates the amount of readjustment a person has to make as a result
of the event. Not all of the events in the scale were necessarily negative or positive
events.
Patients were asked to identify each event that occurred in the past and whether it
is related to their current health condition and then record the corresponding score. In
case an event has occurred more than once patients were instructed to multiply the score
by the number of occurrences. A total score of 300 or more indicates that the patient was
at major risk of illness; a score of 150-299 indicates moderate risk for illness (reduced by
30% from the previous risk), and a score of 150 and below has only a slight risk for
illness. The higher the score (risk) the higher the burden and the more effort needed by
the obese person to return to desirable a weight.
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2. The Hassles and Uplifts Scale
The Hassles and Uplifts Scale is an alternative method to the traditional
life events approach to measuring stressors, and assesses respondents’ attitudes about
daily situations. Instead of focusing on highly charged life events, the 53-item scale
provides a comfortable way to evaluate positive and negative events that occur in each
person's daily life, empowering clients to develop strategies for dealing with hassles and
enhancing the occurrence of uplifts. The Uplifts scale suggests how positive aspects of
daily life counteract the damaging effects of stress. It is graded 0 to 3 on scale of positive
interactions; 1 for somewhat, 2 for quite a bit, and 3 for a great deal, respectively. It takes
approximately 10 minutes to complete the scale (Appendix D).
3. Weight Management Behavior Questionnaires
In addition to the questionnaires used to assess the impact of daily and
major life events, two weight loss behavior questionnaires were used in this study.
Patients were asked to quantify their perceived importance and actual frequency of
engaging in 17 different weight loss promoting behaviors (Appendix A and B). The
questions focused on three main categories of behaviors: self-monitoring, eating, and
exercise. Self-monitoring questions captured data regarding use of food diaries, i.e.,
tracking calories, measuring food portions, logging exercise and weight values. Dietary
habit questions include strictly following menu plans, smaller food portions, meal
planning, restaurant eating, and thoughts about healthy eating. Physical activity questions
reported whether participants exercised at least 60 minutes per day, participated in
supervised sessions on changing exercise-related thinking, and exercised even when not
in the mood.
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4. Anthropometry
Height was measured using a wall mounted stadiometer to the last
completed 0.1 cm after keeping heels, buttocks, shoulders, and occiput in the vertical
plane and head in the anatomic plane. Weight was measured using a digital weighing
scale (Perspective Enterprise, Inc.) with minimal lightweight clothing to the closest 100
g. BMI was calculated by weight (kg)/height (m2). Waist circumference was measured
using a measuring tape; the tape was placed around the bare abdomen just above the
patient's hipbone. The tape was placed snugly but not compressing patient's skin and
held parallel to the floor. The patient was instructed to relax, exhale, and measure their
waist. For measuring hip circumference was the tape was placed at the maximal
circumference over the buttocks.
E. Data Analysis
Data entry based on patient file abstraction was done by the first author using
SAS version 9.2 software for Windows. A random 10% sample was re-entered. The
dependent variables (weight change, BMI change, waist circumference change) were
examined for normality and the distributions were normal and we did not need to apply
transformations. Descriptive analysis was completed for participants’ baseline variables
and expressed as mean +/- standard deviations. Paired t-test was used to evaluate the
change in weight, BMI and waist circumference at 26 weeks. Chi square analysis was
used for categorical variables. Changes in weight, BMI, and waist circumference were
calculated. Analyses used the intent-to-treat approach (with last observation carried
forward).
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Multiple linear regression was utilized to evaluate predictors of weight loss
adjusting for covariates. . The dependent variable was weight loss. Models were adjusted
for baseline weight. Covariates were examined using bi-variable analyses and any
variables that were significant or that changed the beta coefficient of the treatment
variable by 10% were included in the model. . The alpha (p-value) < .05 was used as
criteria for statistical significance.
F. Results
Descriptive statistics for the study participants (n=127) are summarized in
Table 1. The mean age was 51.4 (SD±13.3). At baseline the average weight was 112 kg
(SD ±27.5), and average BMI was 40.5 (SD±8.7). Of the 127 participants, only 100
completed the psychosocial and behavioral questionnaires. However, all 100 of these
completed the treatment and were thus included in the predictive model. Most
participants were female (82%), white (73%), married (62%), had a high school
education or less (44%), were employed (54%), had never attempted to lose weight
(59%,) noted mild activity levels (42%), and never smoked (64%). Mean BMI was 40.5
and many had co-morbidities such as hypertension (46%), depression (40%), high
cholesterol (39%), as well as diabetes (21%), cardiovascular diseases (21%) and thyroid
disease (17%).
Table 2 shows pretreatment test scores for psychosocial and behavioral factors.
The average major life event score at baseline was 331.90 (±183.23) indicating major risk
of illness and difficulty in achieving weight loss success. The average hassles intensity
score was 1.89 (±0.45) and average uplifts score of 2 (±0.41), showing that intervention
group participants experienced a great deal of both hassles and uplifts in daily lives.
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Baseline perceived importance of weight loss enhancing behaviors score was on average
70 .95 (±8.66) out of a maximum possible score of 119. The subscale scores for
perceived importance of self-monitoring, eating, and exercise behaviors were 23.41
(±4.56) of maximum 30 points, 26.21 (±3.03) of maximum 30 points, and 21.59 (±2.58)
of maximum 25 points respectively.
In contrast, the average score for frequency of engaging in weight loss enhancing
behaviors prior to the start of the intervention was 51.27 (±21.76) out of a maximum
possible score of 119. The scores for the subscales of actual engagement in weight loss
promoting behaviors at base line were 14.65 (±9.78) of 42 possible for self-monitoring;
24 (±9.15) of 42 possible for eating, and 15.22 (±7.87) of 35 possible for exercise
behaviors. Table 4 shows the 10 most frequently reported major life change events, daily
hassles and daily uplifts.
There was clinically significant reduction in weight (-7.58kg) and BMI (-2.74
kg/m2) or 6.8%, (pO.OOOl) at 26 weeks (Table 3). Among the psychosocial and
behavioral scales only pre-treatment frequency of engaging in weight loss enhancing
behaviors related to self-monitoring, exercise, and eating; lower scores on depression
(Table 5) also were associated with successful weight loss (p=0.045). Scores for major
life change events and frequency and intensity of daily hassles and uplifts did not predict
weight loss success. Depression was negatively associated with weight loss (p=0.034).
G. Discussion
The aim of this study was to evaluate the association between several
psychosocial pretreatment predictors and success in weight loss in obese and morbidly
obese patients. The benefits of identifying moderators and mediators of weight loss could
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lead to a new generation of interventions (Bauman, et al., 2002; Baranowski, et al, 1999).
Significant predictors of success included pre-treatment levels of engagement in weight
loss-enhancing behaviors such as eating and self-monitoring of physical activity. The
perceived importance of self-monitoring, eating and exercise behaviors did not show
significant effect on outcomes. This is consistent with the findings of Mathur (2007).
Similarly, levels of major life change events, hassles and uplifts frequency & intensity
were not predictive of weight increase or decrease. Notably, baseline depression, which
was highly prevalent (40%), was predictive of lack of weight loss success.
Researchers Tsai andWadden (2005) have recommended that weight loss
programs be evaluated for efficacy since many obese individuals seek them out without
sufficient scientific evidence of program success.
Our findings regarding the association between pre-treatment levels of actual
engagement in weight loss promoting behaviors and weight loss success is in harmony
with previous studies. Engaging in behaviors that promote weight loss such as decreasing
portions, monitoring calorie intake, or using nutritional supplements (Astrup, et al,. 2000;
Brehm, et al., 2003; Samaha, et al., 2003, Yu-Poth, et al., 1999), physical activity
(Boucard, et al., 1990; Wing, 1999) and behavior therapy, (Klem, et al., 1997; McGiure,
et al., 1998; Wyatt, et al., 2002) were found to be associated with successful weight loss
outcomes. Clearly, those who had demonstrated engagement in weight loss behaviors by
attempting to lose weight in the past were more successful, suggesting the need for
participants to give even clinical weight loss programs multiple tries.
Teixeira, et al., (2002) showed that exercise related variables predicted weight
loss success and the sub-scale analysis on exercise in our study also predicted weight

104

loss. However, in another study, Teixeira et al. (2004) found that exercise related
variables did not predict weight loss.
There is ample evidence of a relationship between the number of stressful life
events experienced by an individual and their effects on physical and psychosocial well
being. The Holmes-Rahe scale (Kale & Stenmark, 1983) measures life events in terms of
the changes and readjustment required to return an individual to homeostasis. On average
our study found that nearly all of our participants experienced severe levels of major life
events which could have contributed to a ceiling effect, thus not showing this variable as
important in a multi-variable model.
Additionally, when daily hassles and uplifts were explored by Kanner et al.
(1981) and DeLongis et al. (1982), they found that hassles, defined as minor but more
frequent stressors, have a more profound effect and are more predictive of health
outcomes than major life events. While our study did not find an association between the
frequency and intensity of daily hassles and uplifts and weight loss, data showed that
individuals who were diagnosed with depression were less likely to achieve clinically
significant weight loss.
Participant’s score on the Hassles and Uplifts scale indicates that they appear to
understand the importance of weight loss promoting behaviors. However, this did not
translate to practicing these behaviors as indicated by the lower test scores for the
frequency of engaging in weight loss promoting behaviors compared to higher test scores
for perceived importance of the behaviors. In addition, the list of the 10 most frequently
reported major life events and daily hassles and uplifts provide a potential target for
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interventions aimed at mitigating their effects by helping patients develop effective
coping skills.
Overall, results from this study demonstrate that a medically supervised
comprehensive obesity intervention program that incorporates nutritional, physical
activity and behavior modification successfully facilitated a weight loss of about 7% of
initial weight. This is considered clinically significant due to association in changes with
obesity related health parameters.
There are large individual differences in obesity treatment outcomes. Attempts to
identify predicting variables may be vital to improving treatment protocols. While several
pre-treatment variables were evaluated as predictors of weight loss, only baseline level of
engaging in weight loss promoting behaviors (eating, exercise, and self-monitoring) and
depression were confirmed as a negative predictor of weight loss, suggesting that
clinicians need to be aware of and build on past dieting and life style experiences, and
address the effects of baseline depression on weight loss interventions.
H. Study Limitations
Participants were self-selected in the study and not randomly assigned to groups,
affecting the generalizability of the results. However, this is the case in most clinical and
commercial weight loss programs. Participants were free living and other influences on
weight were not controlled. Patients may have exaggerated responses in order to elicit
sympathy, while some respondents may be too embarrassed to reveal private details or
may have under-reported the severity or frequency of health related information. The
number of questions in the English-language only questionnaire may also have
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influenced compliance with completing the questionnaires. The strength of this study is
the a priori selection of variables to be analyzed as predictors and the low dropout rate.
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Table 5.1 Characteristics of Weight Loss in Lite Weighs
Participants at Baseline
Intervention
(n = 127)

Variables
Female, N (%)
White, N (%)
Age (years), mean (SD)
Married, N (%)
Weight, (kg)
BMI ( kg/m2), mean (SD)
Waist, mean (SD)
Hip, mean (SD)
Waist/Hip ratio, mean (SD)
Education, N (%)
High School or less
Associate Degree
Bachelor's Degree or more
Employment, N (%)
Employed
Unemployed/Disabled/Retired
Past weight loss attempts*, N (%)
No, new participants
Yes, attended previously, N (%)
Physical Activity, N (%)
None
Mild
Moderate/Vigorous
Never smoked, N (%)
No alcohol, N (%)

104
93
49.8
79
112.0
115.5
129.8
0.89

(81.9)
(73.2)
(±15.6)
(62.2)
(27.5)
(±8.7)
(±20.2)
(±18.0)
(±0.09)

55
25
45

(44.0)
(20.0)
(36.0)

68
58

(54.0)
(46.0)

75
52

(59.1)
(40.9)

25
55
47

(19.7)

40.5

83

(43.3)
(37.0)
(63.8)
(65.4)

Diabetes

26

(20.5)

Thyroid
Cardiovascular

21

High cholesterol

51

(16.5)
(21.3)
(39.3)

Hypertension

58

(45.7)

Depression

51

(40.2)

81

Co morbidities* N (%)

27

*Medically supervised commercial weight loss program
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Table 5.2 Pretreatment Scores for Psychosocial and Behavioral Variables
Variables/ Behaviors
Life Event Score
Hassle Intensity
Uplift Intensity
Hassle Frequency
Uplift Frequency
Perceived Importance of Weight Loss Behaviors
(self-monitoring, eating and exercise)
Sub-Scores

Mean
331.90
1.89
2.00
21.35
24.11

SD
183.23
0.45
0.41
9.64
11.45

70.95

8.66

Perceived importance of Self-Monitoring
Perceived importance of Eating Behaviors
Perceived importance of Exercise Behaviors
Frequency of Weight t Loss promoting Behaviors
(self-monitoring, eating and exercise)

23.41
26.21
21.59

4.56
3.03
2.58

51.27

21.76

14.65
24.00
15.22

9.78
9.15
7.87

Sub-Scores
Frequency of Self-monitoring Behaviors
Frequency of Eating Behaviors
Frequency of Exercise Behaviors
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Table 5.3 Change in Anthropometric Measures (after - before)
Measures

Intervention
(n - 127)

Weight change (after - before)

-7.58

(9.7)

Weight change in percent

-6.68

(7.7)

BMI change (after - before)

-2.74

(3.5)

BMI change in percent

-6.68

(7.7)

Waist change (after - before)

-7.19

(9.6)

Waist change in percent
-5.98
(7.6)
*Change in Anthropometric measure is a negative number
Base on Paired t-test analysis
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p-value
<0.0001

<0.0001

<0.0001

Table 5.4 Top 10 frequently reported Major Life Change Events, Daily Hassles and
Daily Uplifts
Rank
1
2
3
4

5

Life Change
Events

F Hassles

F Uplifts

F

Change in eating
habits

50 Your physical appearance

Home entertainment (e.g.,
73 TV, music, reading)

74

Personal injury
or illness

49 Exercise(s)

72 Exercise(s)

68

Death of close
Family members

Taking care of paper work
47 (e.g., paying bills)

Recreation and
66 entertainment outside the

64

Change in health
of family
member

44 Your health

61 Your child(ren)

62

Change in
Finance

Enough money for necessities
41 (e.g. food, clothing, etc)
59 Time spent with family

38 Your physical abilities

Enough money for
necessities (e.g. food,
58 clothing, etc)

61

Change in
sleeping habits

Enough money for
37 emergencies

57 Your friend(s)

60

Change in
responsibilities
at work

32 House work

55 Eating (at home)

60

Vacation

Enough Money for extras (
e.g., entertainment,
32 recreation)

54 Pets

59

31 Being organized

53 Amount of free time

58

6

7
8

61

Mortgage over
$100,000

9

10

Change in living
condition
F=frequency
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Table 5.5 Multiple Regression Analysis for BMI change (after - before)-Using
Hassle/Uplift, (n= 100)
Beta
Intercept
Baseline Weight
Number of Sessions attended
Weight Medication use vs. not
Physical Activity: Mild vs. not
Physical Activity: Moderate/vigorous vs. not
Thyroid vs. none
Depression vs. none
Life Event score
Hassle Frequency score
Uplift Frequency score
Perceived importance of weight loss behaviors
Frequency of Weight Loss promoting
Behaviors (self-monitoring, eating and
exercise)
SB, standard error
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SB

P-value

-2.350
-0.074
0.003
-0.820
0.489
-0.002
0.434
1.613
0.001
-0.017
0.064
0.020

3.496
0.042
0.075
0.767
0.984
1.059
1.027
0.748
0.002
0.047
0.039
0.043

0.5032
0.0863
0.9735
0.2877
0.6207
0.9985
0.6739
0.0338
0.6341
0.7133
0.1038
0.6420

-0.040

0.020

0.0455

CHAPTER 6
CONCLUSION

A. Summary and Limitations
Findings from this study suggest that both weight management approaches (the
intervention group and the comparison group) successfully promoted clinically
significant weight loss (>5%) over a period of 26 weeks. The program that offered a
financial support and required an attendance contract (intervention group) lost about 7%
of their body weight and the usual care program (comparison) lost about 6%. This
difference was not statistically significant. The program that offered a financial incentive
and required an attendance contract did not promote statistically significant weight loss
than the comparison usual care program, but several predictors of success were identified.
It appears that both groups utilized different strategies (pathways) to achieve weight loss.
Comparison group participants depended more on adjunctive weight loss medication use,
while the intervention group attended more intervention sessions and depended more on
behavior modification strategies.
Although the financial support and contractual agreement had no significant effect
on weight loss, there was a strong association between the number of sessions, use of
weight loss medication, BMI/weight at baseline and percent weight loss. Depression was
associated with less success in weight loss.
The pretreatment evaluation of possible psychosocial and behavioral predictors
identified baseline levels of engagement in weight loss enhancing behaviors such as self
monitoring, physical activity and diet as predictors of weight loss. However, perceived
importance of self-monitoring, eating and exercise behaviors did not predict weight loss.
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Similarly, levels of major life change events and the frequency and intensity of hassles
and uplifts were not associated with weight loss. However, we did find that participants
who were diagnosed with depression were less likely to achieve clinically meaningful
weight loss. Interestingly, while this was not associated with weight loss, we found that
participants had experienced severe levels of major life events and high levels of daily
hassles in the past which may have contributed to their obesity. The study did not
evaluate the improvement in the psychosocial and behavioral predictors post
intervention.
This study has several limitations. Participants were free living and other
influences on weight were not controlled. The study may be partially limited due to selfreporting bias. Patients could have exaggerated responses in order to elicit sympathy.
may have been too embarrassed to reveal private details, or may have under-reported the
severity or frequency of health related information in order to minimize their problems.
Participants self-selected into the study and chose the type of intervention they wanted
resulting in non-random group assignment. The length of the questionnaire and language
(English only) could have influenced compliance with completing the questionnaires.
However, the clinical data and data on medication and product use were based on patient
records and thus lacked self-reporting bias.
We did not evaluate specific intervention components such as physical activity,
nutrition, behavior and other lifestyle modifying therapies. Only the outcomes of the
overall program were examined as to the differences in the two approaches with respect
to weight loss. The sample was powered to detect differences in percent weight change
between groups rather than differences in physiological markers of weight change. The
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purpose of the study was to investigate whether an intensive weight management
program offered with financial support to offset program costs was associated with
clinically significant weight loss in obese and morbidly obese patients.
B. Future Studies
Overall our patient population across the two groups was very homogeneous.
Future studies should seek to address race and ethnicity as a factor in overweight and
obesity. While obesity in prevalent in the general population, obesity rates are tend to be
higher among minority populations. Randomization of participant's conditions also was
needed. Future studies should also evaluate the effect of components of treatment such
as physical activity, behavior, diet, and cognitive and other types of therapy. We found
that in our control group weight loss medication was associated with nearly as significant
weight loss as in the intervention group. Future randomized studies comparing weight
loss medication use with behavioral intervention alone could help evaluate the impact of
these strategies of achieving weight loss. Appropriate power is recommended to capture
adequate effect size of intervention features. In our case nearly 80% of participants
completed the programs; however, power was still impacted as we did not recruit as
many participants as originally hoped. Identifying psychosocial and behavioral predictors
could help to match treatment components with individual needs and reduce variance of
individual results in obesity treatment. Comparing pre-treatment and post-treatment
levels of predicting factors for engaging in weight loss enhancing behaviors could help
measure the association with outcomes due to intervention.
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C. Conclusions and Implications
This study has shown that an intensive medically supervised contractual weight
management program is effective in achieving clinically recommended weight loss.
Nevertheless, control group members who designed their own program still achieved
similar results as the intervention group, which had received financial support and an
attendance contract. In general, commercially available weight loss program results are
suboptimal. Thus, a clinically delivered but self-managed program can be as successful
as a more structured intervention. The study also showed that pretreatment levels of
engaging in weight loss enhancing lifestyle behaviors were associated with the success of
the weight loss effort. Clearly, while patients in their past may have failed to achieve
significant weight loss, their efforts were not in vain; previous attempts helped make the
intervention more successful.
In sum, a weight loss program, whether structured or flexible, that is implemented
with the aid of experienced weight loss staff helping guide the patient through the
experience is effective in achieving weight loss. It is significant that while one does not
need a structured (often quite costly) program, that the type of support given to our
control group (standard care) that is covered by most insurance providers is nevertheless
associated with significant weight loss success.
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Appendix A. Weight Loss Behaviors Questionnaire
Name

Weight Loss Behaviors-Lite-Weighs

Directions: The following items ask about what you believe to be important behaviors
for successful weight loss and weight maintenance. Please read each statement carefully
and answer all items. For each item, please indicate how important you believe or feel
that each behavior will contribute to your weight loss success by using the following
scale:
Behaviors
1. To use a diary to write down
everything I eat or drink every day.
2. To follow menu plans when making
food choices.
3. To keep track of the number of
calories I eat
4. To keep track of the amount of fat I
eat.
5. To measure my food portions using
scales, spoons, cups, etc.
6. To purposely eat smaller portions of
food.
7. To attend group weight loss meetings
each week.
8. To keep track of the exercise I do.
9. To exercise at least 30 minutes every
day
10. To take time to plan my meals.
11. To participate in supervised exercise
sessions at the weight loss clinic.
12. To modify the way I cook and
prepare food.
13. To eat out in restaurants less often
than I currently do
14. To change my schedule to make
exercise time a priority.
15. To exercise even when I don’t feel
like it
16. To change my thoughts related to
healthy eating and physical activity
17. To weigh myself at least once a week.

Not at all
Important

Very
Important

Somewhat
Important
2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

1
1

2
2

3
3

4
4

5

1

2
2

3
3

4
4

5
5

1

2

3

4

5

1

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

2

3

4

5

1

1

1

144

5

Adopted from: Mathur, M. (2007). Perceived importance of and willingness to engage in
weight loss behaviors among overweight adults.
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Appendix B. Behavior Frequency Questionnaire
Behavior Frequency Questionnaire-Lite Weighs
Name
Directions: The following items relate to how often you engage in each of the specific
behaviors. Please read each statement carefully and answer all items. For each item,
please indicate on average how many days per week (0-7) you engaged in each specific
behavior during the last four weeks.
Behavior

Circle the number indicating how
many times
per week you have engaged in the
behavior

1. To use a diary to write down everything I
eat or drink.
2. To follow menu plans when making food
choices
3. To record the number of calories I eat.
4. To record the amount of fat I eat.
5. To measure my food portions using scales,
spoons, cups, etc._______________________
6. To purposely eat smaller portions of food.
7. To attend group weight loss meetings.
8. To record the exercise I do.
9. To exercise at least 30 minutes at a moderate
intensity
10. To take time to plan my meals.
11. To participate in supervised exercise
sessions at the weight loss clinic.
12. To modify the way I cook and prepare
food.
13. To eat out in restaurants less often than I
currently do.
14. To change my schedule to make exercise
time a priority._________________________
15. To exercise even when I don’t feel like it.
16. To change my thoughts related to eating
and physical activity.
17. To weigh myself.

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0
0
0

1
1
1

2
2
2

3
3
3

4
4
4

5
5
5

6
6
6

7
7
7

0
0
0
0

1
1
1

2
2
2
2

3
3
3
3

4
4
4
4

5
5
5
5

6
6
6
6

7
7
7
7

0
0

1
1

2
2

3
3

4
4

5
5

6
6

7
7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0

1

2

3

4

5

6

7

0
0

1
1

2
2

3
3

4
4

5
5

6
6

7
7

0

1

2

3

4

5

6

7

1

Adopted from: Mathur, M., Perceived Importance of and Willingness to Engage In
weight loss behaviors among overweight adults. 2007.
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Appendix C. Holmes and Rahe Life Events Scale
NAME
Life Events Scale
Lite-Weighs, Beaver Medical Group
The “Life Events Scale” measures the amount of change, measured in life change units, a
person has experienced and adjusted to in the past. The aim is to identify which of these
events you have experienced in the past which may have affected your overall health.
Directions
Read each of the events listed on the next page, and circle the amount next to any event
which has occurred in your life in the last two or more years. You may want to consider
extending the timeline (e.g. 5yrs, lOyrs or more), if you believe it might be relevant to
your current weight or other obesity related conditions. If an event occurred more than
once, multiply the score for that event by the number of times that the event occurred.

Adapted from Holmes-Rahe Social Readjustment Rating Scale. Journal of Psychosomatic
Research, (1967). Vol. 11, pp. 213-218.
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HOLMES-RAHE LIFE EVENTS INVENTORY
Lite-Weighs, Beaver Medical Group
Life Events

Death of spouse
Divorce
Martial separation
Jail term
Death of close family
member
Personal injury or illness
Marriage
Fired at work
Marital reconciliation
Retirement
Change in health of a
family member
Pregnancy
Sex Difficulties
Gain of new family
member
Business readjustment
Change in financial state
Death of close friend
Change to different line of
work
Change in number of
arguments with spouse
Mortgage over $100,000
Foreclosure of mortgage or
loan
Change in responsibilities
at work

Life
Years
Changes since event
Life Events
Units
100
Son or daughter leaving
home
73
Trouble with in-laws
65
Outstanding personal
63
achievement
63
Wife begins or stops work
Begin or end school
53
Change in living conditions
50
Revision in personal habits
47
Trouble with boss
45
Change in work hours or
45
conditions
44
Change in residence
Change in schools
40
Change in recreation
39
Change in church activities
39
Change in social activities
39
Mortgage or loan less than
$30,000
38
Change in sleeping habits
37
Change in number of
36
family get-togethers
Change in eating habits
35
Vacation
31
Christmas alone
Minor violations of the law
30
TOTAL SCORE
T

Life
Years
Changes since event
Units
29
29

-

28

26
26

H

25
24
23

_j
j

20
20
20

19
19
18

7

4
J

T~

17
16
15
15
13
12

i

r

29

Adapted from Holmes-Rahe Social Readjustment Rating Scale. Journal of Psychosomatic
Research, (1967). Vol. 11, pp. 213-218.
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Appendix D. The Hassles and Uplifts Scale
The Hassles and Uplifts Scale - Lite Weighs

NAME

HASSLES are irritants—things that annoy or bother you; they can make you upset or
angry.
UPLIFTS are events that make you feel good; they can make you joyful, glad, or
satisfied. Some hassles and uplifts occur on a fairly regular basis and others are relatively
rare. Some have only a slight effect, while others have a strong effect.

This questionnaire lists things that can be hassles and uplifts in day-to-day life. You will
find that during the course of a day some of these things will have been only a hassle for
you and some will have been only an uplift. Others will have been both a hassle AND an
uplift.

DIRECTIONS: Please think about how much of a hassle and how much of an uplift
each item was for you today. Please indicate on the left-hand side of the page (under
“HASSLES”) how much of a hassle the item was by circling the appropriate number.
Then indicate on the right-hand side of the page (under “UPLIFTS”) how much of an
uplift it was for you by circling the appropriate number. Remember, circle one number
on the left-hand side of the page and one number on the right-hand side of the page for
each item.
PLEASE FILL OUT THIS QUESTIONNAIRE TODAY
How much of a hassle was
How much of an uplift was
this item for you today?
this item for you? today?
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HASSLES
0 = None or not applicable
1 = Somewhat
2 = Quite a bit
3 = A great deal

0
1
2
3

UPLIFTS
= None or not applicable
= Somewhat
= Quite a bit
= A great deal

DIRECTIONS: Please circle one number on the left-hand side and one number on the
right-hand side for each item.
CATEGORIES

HASSLES
UPLIFTS
0 123

Your child(ren)

0 123

0 123

2.

Your parents or parents-in-law

0 123

0 123

3.

Other relative(s)

0 123

0 123

4.

Your spouse

0 12 3

0 12 3

5.

Time spent with family

0 12 3

0 12 3

6.

Health or well-being of a family member

0 123

0 123

7.

Sex

0 123

0 123

8.

Intimacy

0 123

0 123

9.

Family-related obligations

0 123

0 123

10.

Your ffiend(s)

0 123

0 123

11.

Fellow workers

0 123

0 123

12.

Clients, customers, patients, etc.

0 123

0 123

13.

Your supervisor or employer

0 123

0 123

14.

The nature of your work

0 123

0 12 3

15.

Your work load

0 123

0 123

16.

Your job security

0 123

0 123

17.

Meeting deadlines or goals on the job

0 123

0 123

18.

Enough money for necessities (e.g., food, clothing,
housing, health care, taxes, insurance)

0 123

0 123

19.

Enough money for education

0 123

0 123

20.

Enough money for emergencies

0 123

0 123

21.

Enough money for extras (e.g., entertainment,
recreation, vacations)

0 123

22.

0 123

Financial care for someone who doesn’t live with you
0 123

0 123

23.

Investments

0 123

0 123

24.

Your smoking

0 123

0 123

25.

Your drinking

0 123

0 123

26.

Mood-altering drugs

0 123

0 123

27.

Your physical appearance

0 12 3
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Categories

HASSLES

UPLIFTS

Contraception

0 123

29.

Exercise(s)

0 123

0 123

30.

Your medical care

0 123

0 123

31.

Your health

0 123

0 123

32.

Your physical abilities

0 123

0 123

33.

The weather

0 123

0 123

34.

News events

0 12 3

0 123

35.

Your environment (e.g.„ quality of air, noise level,
greenery)

0 12 3

0 123

36.

Political or social issues

0 123

0 123

37.

Your neighbourhood (e.g., neighbours, setting)

0 12 3

0 123

38.

Conserving (gas, electricity, water, gasoline, etc.)

0 123

0 123

39.

Pets

0 123

0 123

40.

Cooking

0 12 3

0 123

41.

Housework

0 123

0 123

42.

Home repairs

0 123

0 123

43.

Y ardwork

0 12 3

0 123

44.

Car maintenance

0 123

0 123

45.

Taking care of paperwork (e.g.„ paying bills,

0 123

28.

0 123

filling out forms)

0 123

0 123

46.

Home entertainment (e.g.„ TV, music, reading)

0 123

0 123

47.

Amount of free time

0 123

0 123

48.

Recreation and entertainment outside the home
(e.g., movies, sports, eating out, walking)

0 123

0 123

49.

Eating (at home)

0 123

0 123

50.

Church or community organizations

0 123

0 123

51.

Legal matters

0 123

0 123

52.

Being organized

0 123

0 123

53.

Social commitments

0 123

Source: DeLongis, A., Folkman, S., & Lazarus, R. (1988). The impact of daily stress on
health and mood: Psychological social resources as mediators. Journal of Personality and
Social Psychology, 54, 486^195. Copyright © 1988 by the American Psychological
Association. Reprinted with permission.
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Appendix E. Proposed Budget
Items
□

SAS software

□

Stationary

□

Computer Note book

□

Travel

□
□
□
□

Xerox
Statistician
Editing
Miscellaneous

Cost

Justification
Data Entry and Analysis

$250.00

Supplies

$300.00

Data collection and Entry

$1700.00

Travel to Beaver Medical Group
Travel to LEU for conferences

$500.00

Questionnaires
Data Analysis
Editing
Food and other amenities

$500.00
$600.00
$450.00
$350.00

Total

$4650.00
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